Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:fluoranthene
go back to main search page
Accession:CHEBI:33083 term browser browse the term
Definition:An ortho- and peri-fused polycyclic arene consisting of a naphthalene and benzene unit connected by a five-membered ring.
Synonyms:related_synonym: Formula=C16H10;   InChI=1S/C16H10/c1-2-8-13-12(7-1)14-9-3-5-11-6-4-10-15(13)16(11)14/h1-10H;   InChIKey=GVEPBJHOBDJJJI-UHFFFAOYSA-N;   SMILES=c1ccc-2c(c1)-c1cccc3cccc-2c13;   benzo[jk]fluorene
 xref: Beilstein:1907918;   CAS:206-44-0;   Gmelin:262216;   KEGG:C19425
 xref_mesh: MESH:C007738
 xref: MetaCyc:CPD-15564;   PMID:15278918;   PMID:17258277;   PMID:23943046;   PMID:24151025;   Reaxys:1907918;   Wikipedia:Fluoranthene


show annotations for term's descendants           Sort by:
 
fluoranthene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of A2M mRNA CTD PMID:17690111 NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
JBrowse link
G Aacs acetoacetyl-CoA synthetase decreases expression ISO fluoranthene results in decreased expression of AACS mRNA CTD PMID:28329830 NCBI chr12:36,512,393...36,555,694
Ensembl chr12:36,512,393...36,555,694
JBrowse link
G Abcd1 ATP binding cassette subfamily D member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ABCD1 mRNA CTD PMID:28329830 NCBI chr  X:157,073,860...157,095,652
Ensembl chr  X:157,072,736...157,095,274
JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA CTD PMID:18711122 NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
JBrowse link
G Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABL2 mRNA CTD PMID:28329830 NCBI chr13:74,154,533...74,333,244
Ensembl chr13:74,154,835...74,333,244
JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABTB2 mRNA CTD PMID:28329830 NCBI chr 3:93,494,706...93,648,750
Ensembl chr 3:93,495,106...93,647,721
JBrowse link
G Acad10 acyl-CoA dehydrogenase family, member 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ACAD10 mRNA CTD PMID:28329830 NCBI chr12:40,417,918...40,460,562
Ensembl chr12:40,417,944...40,460,561
JBrowse link
G Acbd3 acyl-CoA binding domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ACBD3 mRNA CTD PMID:28329830 NCBI chr13:99,004,942...99,035,520
Ensembl chr13:99,004,942...99,035,519
JBrowse link
G Acot2 acyl-CoA thioesterase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ACOT2 mRNA CTD PMID:28329830 NCBI chr 6:107,460,596...107,468,324
Ensembl chr 6:107,460,668...107,467,487
JBrowse link
G Acox2 acyl-CoA oxidase 2 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ACOX2 mRNA CTD PMID:18711122 NCBI chr15:18,449,304...18,481,472
Ensembl chr15:18,451,144...18,481,470
JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 decreases expression ISO fluoranthene results in decreased expression of ACSL3 mRNA CTD PMID:28329830 NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ACSL4 mRNA CTD PMID:28329830 NCBI chr  X:113,596,247...113,660,024
Ensembl chr  X:113,596,239...113,659,944
JBrowse link
G Acy3 aminoacylase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ACY3 mRNA CTD PMID:28329830 NCBI chr 1:219,233,712...219,237,103
Ensembl chr 1:219,233,750...219,237,098
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADAMTS1 mRNA CTD PMID:28329830 NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADAMTS4 mRNA CTD PMID:28329830 NCBI chr13:89,622,996...89,632,485
Ensembl chr13:89,622,632...89,634,419
JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif, 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADAMTS5 mRNA CTD PMID:28329830 NCBI chr11:25,411,174...25,456,639
Ensembl chr11:25,410,975...25,456,836
JBrowse link
G Adgrd1 adhesion G protein-coupled receptor D1 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADGRD1 mRNA
fluoranthene results in decreased expression of ADGRD1 mRNA
CTD PMID:28329830 NCBI chr12:31,134,806...31,249,594
Ensembl chr12:31,136,741...31,249,118
JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADH1 mRNA CTD PMID:28329830 NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide increases expression
multiple interactions
ISO fluoranthene results in increased expression of ADH7 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of ADH7 mRNA
CTD PMID:28329830 NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
JBrowse link
G Adi1 acireductone dioxygenase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADI1 mRNA CTD PMID:28329830 NCBI chr 6:47,940,211...47,947,173
Ensembl chr 6:47,940,183...47,947,230
JBrowse link
G Aff1 AF4/FMR2 family, member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AFF1 mRNA CTD PMID:28329830 NCBI chr14:7,222,883...7,384,916
Ensembl chr14:7,226,586...7,384,876
JBrowse link
G Aftph aftiphilin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AFTPH mRNA CTD PMID:28329830 NCBI chr14:104,921,633...104,975,763
Ensembl chr14:104,922,282...104,960,141
JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
increases activity
ISO
EXP
[benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; [fluoranthene co-treated with Benzo(a)pyrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; fluoranthene promotes the reaction [pyrene results in increased activity of AHR protein]; pyrene promotes the reaction [fluoranthene results in increased activity of AHR protein]
fluoranthene analog results in increased activity of AHR protein
CTD PMID:17665671, PMID:25500124, PMID:28710019, PMID:30980910 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor increases expression
multiple interactions
EXP
ISO
fluoranthene results in increased expression of AHRR mRNA
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]
TNF protein inhibits the reaction [fluoranthene results in increased expression of AHRR mRNA]
CTD PMID:25268939, PMID:28710019, PMID:30980910 NCBI chr 1:31,603,297...31,698,329
Ensembl chr 1:31,603,297...31,698,329
JBrowse link
G Ak4 adenylate kinase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AK4 mRNA CTD PMID:28329830 NCBI chr 5:120,250,318...120,309,153
Ensembl chr 5:120,250,616...120,305,897
JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B multiple interactions ISO
EXP
[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA
CTD PMID:17690111, PMID:18711122 NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
multiple interactions
ISO fluoranthene results in increased expression of ALDH3A1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of ALDH3A1 mRNA
CTD PMID:28329830 NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
JBrowse link
G Aldob aldolase, fructose-bisphosphate B multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ALDOB mRNA CTD PMID:17690111 NCBI chr 5:64,805,772...64,818,813
Ensembl chr 5:64,805,773...64,818,824
JBrowse link
G Alkbh7 alkB homolog 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ALKBH7 mRNA CTD PMID:28329830 NCBI chr 9:10,045,375...10,047,507
Ensembl chr 9:10,045,375...10,047,507
JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AMPD3 mRNA CTD PMID:28329830 NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467
JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ANGPTL4 mRNA CTD PMID:28329830 NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
JBrowse link
G Ankrd11 ankyrin repeat domain 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ANKRD11 mRNA CTD PMID:28329830 NCBI chr19:55,703,831...55,862,446
Ensembl chr19:55,703,824...55,737,500
JBrowse link
G Ankrd37 ankyrin repeat domain 37 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ANKRD37 mRNA CTD PMID:28329830 NCBI chr16:49,463,016...49,465,905
Ensembl chr16:49,462,889...49,465,888
JBrowse link
G Antxr2 ANTXR cell adhesion molecule 2 increases expression
multiple interactions
ISO fluoranthene results in increased expression of ANTXR2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of ANTXR2 mRNA
CTD PMID:28329830 NCBI chr14:13,191,716...13,331,286
Ensembl chr14:13,192,347...13,274,978
JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AP1S1 mRNA CTD PMID:28329830 NCBI chr12:22,665,128...22,676,079
Ensembl chr12:22,665,112...22,676,075
JBrowse link
G Apln apelin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of APLN mRNA CTD PMID:28329830 NCBI chr  X:134,856,719...134,866,210
Ensembl chr  X:134,856,726...134,866,210
JBrowse link
G Apobr apolipoprotein B receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of APOBR mRNA CTD PMID:28329830 NCBI chr 1:197,999,209...198,003,839
Ensembl chr 1:197,999,037...198,003,839
JBrowse link
G Apoc3 apolipoprotein C3 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of APOC3 mRNA CTD PMID:17690111 NCBI chr 8:50,529,318...50,531,498
Ensembl chr 8:50,529,318...50,531,498
JBrowse link
G Ar androgen receptor multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; fluoranthene binds to and results in decreased activity of AR protein; fluoranthene inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:10771140, PMID:18324785, PMID:30980910 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arap2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARAP2 mRNA CTD PMID:28329830 NCBI chr14:48,726,033...48,922,809
Ensembl chr14:48,726,045...48,922,983
JBrowse link
G Arfgap1 ADP-ribosylation factor GTPase activating protein 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ARFGAP1 mRNA CTD PMID:18711122 NCBI chr 3:176,475,847...176,490,642
Ensembl chr 3:176,475,893...176,489,925
JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARHGEF2 mRNA CTD PMID:28329830 NCBI chr 2:187,964,100...188,022,847
Ensembl chr 2:187,977,008...188,021,377
JBrowse link
G Arhgef28 Rho guanine nucleotide exchange factor 28 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARHGEF28 mRNA CTD PMID:28329830 NCBI chr 2:25,738,514...26,011,429
Ensembl chr 2:25,738,514...26,011,429
JBrowse link
G Arid5a AT-rich interaction domain 5A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARID5A mRNA CTD PMID:28329830 NCBI chr 9:42,871,907...42,886,725
Ensembl chr 9:42,871,950...42,884,855
JBrowse link
G Arl2bp ADP-ribosylation factor like GTPase 2 binding protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ARL2BP mRNA CTD PMID:28329830 NCBI chr19:10,753,670...10,763,247
Ensembl chr19:10,753,681...10,763,110
JBrowse link
G Arl5b ADP-ribosylation factor like GTPase 5B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARL5B mRNA CTD PMID:28329830 NCBI chr17:82,065,893...82,092,693
Ensembl chr17:82,065,937...82,091,362
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA CTD PMID:28710019 NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
JBrowse link
G Arrdc4 arrestin domain containing 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ARRDC4 mRNA CTD PMID:28329830 NCBI chr 1:129,766,097...129,780,076
Ensembl chr 1:129,766,100...129,780,356
JBrowse link
G Arsj arylsulfatase family, member J multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ARSJ mRNA CTD PMID:28329830 NCBI chr 2:230,163,014...230,662,084 JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ASAP2 mRNA CTD PMID:28329830 NCBI chr 6:43,231,178...43,348,606
Ensembl chr 6:43,234,526...43,343,551
JBrowse link
G Ascc3 activating signal cointegrator 1 complex subunit 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ASCC3 mRNA CTD PMID:28329830 NCBI chr20:55,253,670...55,557,249
Ensembl chr20:55,253,686...55,556,473
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ATF3 mRNA CTD PMID:28329830 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ATF4 mRNA CTD PMID:28329830 NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
JBrowse link
G Atoh8 atonal bHLH transcription factor 8 increases expression ISO fluoranthene results in increased expression of ATOH8 mRNA CTD PMID:28329830 NCBI chr 4:100,067,341...100,099,517
Ensembl chr 4:100,067,341...100,099,517
JBrowse link
G Atox1 antioxidant 1 copper chaperone multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ATOX1 mRNA CTD PMID:28329830 NCBI chr10:40,790,850...40,805,886
Ensembl chr10:40,790,845...40,805,941
JBrowse link
G Atp23 ATP23 metallopeptidase and ATP synthase assembly factor homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ATP23 mRNA CTD PMID:28329830 NCBI chr 7:70,183,625...70,198,655
Ensembl chr 7:70,183,625...70,198,655
JBrowse link
G Avl9 AVL9 cell migration associated multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AVL9 mRNA CTD PMID:28329830 NCBI chr 4:87,026,471...87,070,738
Ensembl chr 4:87,026,530...87,066,356
JBrowse link
G Axin2 axin 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AXIN2 mRNA CTD PMID:28329830 NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of BAX mRNA CTD PMID:17690111 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bbs7 Bardet-Biedl syndrome 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BBS7 mRNA CTD PMID:28329830 NCBI chr 2:123,283,402...123,322,991
Ensembl chr 2:123,283,388...123,323,170
JBrowse link
G Bcl10 BCL10, immune signaling adaptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL10 mRNA CTD PMID:28329830 NCBI chr 2:251,805,392...251,814,957
Ensembl chr 2:251,805,392...251,814,957
JBrowse link
G Bcl3 BCL3, transcription coactivator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA] CTD PMID:28329830 NCBI chr 1:80,730,758...80,745,273
Ensembl chr 1:80,730,499...80,744,831
JBrowse link
G Bcl6 BCL6, transcription repressor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL6 mRNA CTD PMID:28329830 NCBI chr11:80,255,790...80,279,075
Ensembl chr11:80,255,790...80,279,075
JBrowse link
G Bcl9 BCL9, transcription coactivator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BCL9 mRNA CTD PMID:28329830 NCBI chr 2:199,334,644...199,420,083
Ensembl chr 2:199,334,664...199,354,793
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BDNF mRNA CTD PMID:28329830 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BIRC3 mRNA CTD PMID:28329830 NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
JBrowse link
G Blzf1 basic leucine zipper nuclear factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BLZF1 mRNA CTD PMID:28329830 NCBI chr13:82,592,170...82,607,379
Ensembl chr13:82,592,170...82,607,379
JBrowse link
G Bmp2k BMP-2 inducible kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BMP2K mRNA CTD PMID:28329830 NCBI chr14:14,126,086...14,226,823
Ensembl chr14:14,129,725...14,192,048
JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BNIP3 mRNA CTD PMID:28329830 NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282
JBrowse link
G Brd1 bromodomain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BRD1 mRNA CTD PMID:28329830 NCBI chr 7:129,676,119...129,724,303
Ensembl chr 7:129,676,120...129,724,303
JBrowse link
G Btaf1 B-TFIID TATA-box binding protein associated factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTAF1 mRNA CTD PMID:28329830 NCBI chr 1:255,564,247...255,654,932
Ensembl chr 1:255,564,409...255,654,932
JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTG1 mRNA CTD PMID:28329830 NCBI chr 7:37,812,831...37,815,088
Ensembl chr 7:37,812,831...37,815,088
JBrowse link
G Btg2 BTG anti-proliferation factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTG2 mRNA CTD PMID:28329830 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
JBrowse link
G C1rl complement C1r subcomponent like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of C1RL mRNA CTD PMID:28329830 NCBI chr 4:157,108,190...157,122,689
Ensembl chr 4:157,107,469...157,123,446
JBrowse link
G Calm3 calmodulin 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CALM3 mRNA CTD PMID:28329830 NCBI chr 1:78,844,520...78,851,628
Ensembl chr 1:78,843,080...78,851,719
JBrowse link
G Cars cysteinyl-tRNA synthetase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CARS mRNA CTD PMID:28329830 NCBI chr 1:216,759,367...216,801,652
Ensembl chr 1:216,759,366...216,801,656
JBrowse link
G Casp4 caspase 4 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CASP4 mRNA
fluoranthene results in increased expression of CASP4 mRNA
CTD PMID:28329830 NCBI chr 8:2,616,391...2,651,682
Ensembl chr 8:2,635,851...2,651,652
JBrowse link
G Cavin1 caveolae associated protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CAVIN1 mRNA CTD PMID:28329830 NCBI chr10:88,862,513...88,874,495
Ensembl chr10:88,860,733...88,874,528
JBrowse link
G Cavin3 caveolae associated protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CAVIN3 mRNA CTD PMID:28329830 NCBI chr 1:170,317,099...170,318,688
Ensembl chr 1:170,317,113...170,318,935
JBrowse link
G Cby1 chibby family member 1, beta catenin antagonist multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CBY1 mRNA CTD PMID:28329830 NCBI chr 7:120,891,930...120,898,318
Ensembl chr 7:120,891,940...120,897,687
JBrowse link
G Ccdc186 coiled-coil domain containing 186 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCDC186 mRNA CTD PMID:28329830 NCBI chr 1:277,603,601...277,635,379
Ensembl chr 1:277,606,995...277,629,196
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA] CTD PMID:28329830 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA] CTD PMID:28329830 NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCN1 mRNA CTD PMID:28329830 NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
JBrowse link
G Ccna2 cyclin A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CCNA2 mRNA CTD PMID:28329830 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CCND1 mRNA CTD PMID:28329830 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccne2 cyclin E2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CCNE2 mRNA CTD PMID:28329830 NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
JBrowse link
G Ccnl1 cyclin L1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCNL1 mRNA CTD PMID:28329830 NCBI chr 2:157,747,295...157,759,838
Ensembl chr 2:157,747,542...157,759,838
JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCR7 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCR7 mRNA] CTD PMID:28329830 NCBI chr10:87,057,335...87,067,444
Ensembl chr10:87,057,136...87,067,456
JBrowse link
G Ccser1 coiled-coil serine-rich protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCSER1 mRNA CTD PMID:28329830 NCBI chr 4:91,235,885...92,516,800
Ensembl chr 4:91,373,942...91,972,325
JBrowse link
G Cdc42ep3 CDC42 effector protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CDC42EP3 mRNA CTD PMID:28329830 NCBI chr 6:1,922,500...1,942,972
Ensembl chr 6:1,922,500...1,942,972
JBrowse link
G Cdc6 cell division cycle 6 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDC6 mRNA
fluoranthene results in decreased expression of CDC6 mRNA
CTD PMID:28329830 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CDH1 mRNA CTD PMID:17690111 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
JBrowse link
G Cdh17 cadherin 17 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CDH17 mRNA CTD PMID:18711122 NCBI chr 5:25,354,187...25,443,675
Ensembl chr 5:25,391,115...25,443,718
JBrowse link
G Cdipt CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDIPT mRNA CTD PMID:28329830 NCBI chr 1:198,409,186...198,413,497
Ensembl chr 1:198,409,360...198,413,497
JBrowse link
G Cdk18 cyclin-dependent kinase 18 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CDK18 mRNA CTD PMID:28329830 NCBI chr13:48,893,525...48,926,673
Ensembl chr13:48,893,412...48,927,483
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CDKN1A mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of CDKN1A mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CDKN1A mRNA]
CTD PMID:17690111, PMID:28329830 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDKN2C mRNA CTD PMID:28329830 NCBI chr 5:129,347,731...129,352,886
Ensembl chr 5:129,347,732...129,352,886
JBrowse link
G Cdon cell adhesion associated, oncogene regulated multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDON mRNA
fluoranthene results in decreased expression of CDON mRNA
CTD PMID:28329830 NCBI chr 8:36,625,757...36,712,091
Ensembl chr 8:36,625,733...36,710,949
JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CDR2 mRNA CTD PMID:28329830 NCBI chr 1:190,889,698...190,914,606
Ensembl chr 1:190,889,701...190,914,610
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPB mRNA CTD PMID:28329830 NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPD mRNA CTD PMID:28329830 NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPG mRNA CTD PMID:28329830 NCBI chr 1:91,286,956...91,297,459
Ensembl chr 1:91,287,917...91,296,656
JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPZ mRNA CTD PMID:28329830 NCBI chr 6:1,516,804...1,534,488
Ensembl chr 6:1,516,804...1,534,488
JBrowse link
G Cebpzos CEBPZ opposite strand multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CEBPZOS mRNA CTD PMID:28329830 NCBI chr 6:1,514,191...1,518,858
Ensembl chr 6:1,516,158...1,517,618
JBrowse link
G Cemip cell migration inducing hyaluronidase decreases expression ISO fluoranthene results in decreased expression of CEMIP mRNA CTD PMID:28329830 NCBI chr 1:146,069,774...146,226,320
Ensembl chr 1:146,069,771...146,226,462
JBrowse link
G Cenpx centromere protein X multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CENPX mRNA CTD PMID:28329830 NCBI chr10:109,890,904...109,893,804 JBrowse link
G Cep85l centrosomal protein 85-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEP85L mRNA CTD PMID:28329830 NCBI chr20:34,574,043...34,743,142
Ensembl chr20:34,575,950...34,684,418
JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHAC1 mRNA CTD PMID:28329830 NCBI chr 3:111,160,205...111,163,425
Ensembl chr 3:111,160,205...111,163,425
JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHD2 mRNA CTD PMID:28329830 NCBI chr 1:134,757,934...134,873,053
Ensembl chr 1:134,757,934...134,871,167
JBrowse link
G Chek2 checkpoint kinase 2 increases expression
multiple interactions
ISO fluoranthene results in increased expression of CHEK2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of CHEK2 mRNA
CTD PMID:28329830 NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
JBrowse link
G Chic2 cysteine-rich hydrophobic domain 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHIC2 mRNA CTD PMID:28329830 NCBI chr14:35,683,657...35,718,005
Ensembl chr14:35,683,442...35,717,922
JBrowse link
G Chka choline kinase alpha multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHKA mRNA CTD PMID:28329830 NCBI chr 1:219,076,618...219,126,221
Ensembl chr 1:219,077,771...219,126,220
JBrowse link
G Chst12 carbohydrate sulfotransferase 12 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CHST12 mRNA CTD PMID:28329830 NCBI chr12:16,199,975...16,218,404
Ensembl chr12:16,200,019...16,201,632
JBrowse link
G Cldn25 claudin 25 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLDN25 mRNA
fluoranthene results in increased expression of CLDN25 mRNA
CTD PMID:28329830 NCBI chr 8:53,360,490...53,362,387
Ensembl chr 8:53,361,323...53,362,006
JBrowse link
G Cldn7 claudin 7 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CLDN7 mRNA CTD PMID:18711122 NCBI chr10:56,576,326...56,578,632
Ensembl chr10:56,576,428...56,578,626
JBrowse link
G Clec2d C-type lectin domain family 2, member D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLEC2D mRNA CTD PMID:28329830 NCBI chr 4:162,278,252...162,302,881
Ensembl chr 4:162,292,305...162,302,156
JBrowse link
G Clk1 CDC-like kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLK1 mRNA CTD PMID:28329830 NCBI chr 9:65,296,777...65,308,017
Ensembl chr 9:65,296,778...65,307,995
JBrowse link
G Clk4 CDC-like kinase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLK4 mRNA CTD PMID:28329830 NCBI chr10:36,715,565...36,733,473
Ensembl chr10:36,715,565...36,733,133
JBrowse link
G Cmtr2 cap methyltransferase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CMTR2 mRNA CTD PMID:28329830 NCBI chr19:41,426,536...41,433,367
Ensembl chr19:41,427,504...41,433,346
JBrowse link
G Cnnm4 cyclin and CBS domain divalent metal cation transport mediator 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CNNM4 mRNA CTD PMID:28329830 NCBI chr 9:43,049,587...43,088,690
Ensembl chr 9:43,049,587...43,088,702
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein CTD PMID:28710019 NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
JBrowse link
G Coprs coordinator of PRMT5 and differentiation stimulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of COPRS mRNA CTD PMID:28329830 NCBI chr16:80,826,681...80,831,791
Ensembl chr16:80,826,681...80,831,791
JBrowse link
G Coq10b coenzyme Q10B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of COQ10B mRNA CTD PMID:28329830 NCBI chr 9:61,655,963...61,675,880
Ensembl chr 9:61,655,963...61,675,873
JBrowse link
G Cox20 cytochrome c oxidase assembly factor COX20 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of COX20 mRNA CTD PMID:28329830 NCBI chr13:96,219,853...96,224,023
Ensembl chr13:96,219,853...96,224,023
JBrowse link
G Cp ceruloplasmin multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CP mRNA CTD PMID:17690111 NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
JBrowse link
G Cpeb4 cytoplasmic polyadenylation element binding protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CPEB4 mRNA CTD PMID:28329830 NCBI chr10:15,984,520...16,047,209
Ensembl chr10:15,987,921...16,046,033
JBrowse link
G Cpox coproporphyrinogen oxidase increases expression
multiple interactions
ISO fluoranthene results in increased expression of CPOX mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of CPOX mRNA
CTD PMID:28329830 NCBI chr11:44,039,665...44,049,648
Ensembl chr11:44,039,669...44,049,648
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CPT2 mRNA CTD PMID:28329830 NCBI chr 5:127,505,646...127,523,016
Ensembl chr 5:127,505,614...127,523,089
JBrowse link
G Creb5 cAMP responsive element binding protein 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CREB5 mRNA CTD PMID:28329830 NCBI chr 4:83,390,782...83,840,356
Ensembl chr 4:83,391,283...83,836,351
JBrowse link
G Crebrf CREB3 regulatory factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CREBRF mRNA CTD PMID:28329830 NCBI chr10:16,693,846...16,753,162
Ensembl chr10:16,694,792...16,752,205
JBrowse link
G Crip1 cysteine rich protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CRIP1 mRNA CTD PMID:28329830 NCBI chr 6:137,959,171...137,967,042
Ensembl chr 6:137,959,171...137,967,042
JBrowse link
G Csdc2 cold shock domain containing C2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CSDC2 mRNA CTD PMID:28329830 NCBI chr 7:123,168,811...123,183,336
Ensembl chr 7:123,168,811...123,183,335
JBrowse link
G Csgalnact2 chondroitin sulfate N-acetylgalactosaminyltransferase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CSGALNACT2 mRNA CTD PMID:28329830 NCBI chr 4:150,148,626...150,185,062
Ensembl chr 4:150,153,844...150,185,044
JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CSRNP1 mRNA CTD PMID:28329830 NCBI chr 8:128,659,883...128,673,339
Ensembl chr 8:128,659,868...128,672,284
JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CTTNBP2NL mRNA CTD PMID:28329830 NCBI chr 2:207,495,056...207,541,808
Ensembl chr 2:207,495,055...207,541,645
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CXCL10 mRNA CTD PMID:28329830 NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CXCL1 mRNA CTD PMID:28329830 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
affects expression
decreases activity
ISO
EXP
[fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]
fluoranthene results in increased expression of CYP1A1 mRNA; fluoranthene results in increased expression of CYP1A1 protein
fluoranthene affects the expression of CYP1A1 mRNA
fluoranthene results in decreased activity of CYP1A1 protein
1,2,5,6-dibenzanthracene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; fluoranthene inhibits the reaction [benzo(k)fluoranthene results in increased activity of CYP1A1 protein]; fluoranthene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; fluoranthene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]
CTD PMID:7750161, PMID:9586956, PMID:12107646, PMID:16269432, PMID:18711122, PMID:21784029, PMID:25268939, PMID:27099206, PMID:27196671, PMID:28710019, PMID:30980910 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression
multiple interactions
ISO
EXP
fluoranthene results in increased expression of CYP1A2 mRNA
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA
[fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA
CTD PMID:7750161, PMID:12107646, PMID:18711122, PMID:21784029 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity
multiple interactions
increases expression
affects expression
EXP
ISO
[fluoranthene results in decreased activity of CYP1B1 protein] which results in decreased activity of dibenzo(a,l)pyrene
[1-methylanthracene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1B1 mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased expression of CYP1B1 mRNA
fluoranthene results in increased expression of CYP1B1 mRNA
fluoranthene affects the expression of CYP1B1 mRNA
[fluoranthene results in decreased activity of CYP1B1 protein] which results in decreased susceptibility to dibenzo(a,l)pyrene; fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of CYP1B1 mRNA]
CTD PMID:17961608, PMID:25268939, PMID:27099206, PMID:27196671, PMID:28329830, PMID:29170806 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression ISO fluoranthene results in increased expression of CYP2E1 mRNA CTD PMID:16269432 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp51 cytochrome P450, family 51 decreases expression ISO fluoranthene results in decreased expression of CYP51 mRNA CTD PMID:28329830 NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DDIT3 mRNA CTD PMID:28329830 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DDIT4 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DDIT4 mRNA] CTD PMID:28329830 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
JBrowse link
G Ddx5 DEAD-box helicase 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DDX5 mRNA CTD PMID:28329830 NCBI chr10:94,979,759...94,988,461
Ensembl chr10:94,980,928...94,988,461
JBrowse link
G Defb1 defensin beta 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DEFB1 mRNA CTD PMID:28329830 NCBI chr16:75,294,385...75,309,127
Ensembl chr16:75,294,376...75,309,176
JBrowse link
G Dexi Dexi homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DEXI mRNA CTD PMID:28329830 NCBI chr10:5,199,226...5,211,913
Ensembl chr10:5,199,226...5,211,913
JBrowse link
G Dhcr24 24-dehydrocholesterol reductase multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DHCR24 mRNA
fluoranthene results in decreased expression of DHCR24 mRNA
CTD PMID:28329830 NCBI chr 5:126,164,708...126,188,926
Ensembl chr 5:126,164,674...126,191,206
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DHCR7 mRNA
fluoranthene results in decreased expression of DHCR7 mRNA
CTD PMID:28329830 NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
JBrowse link
G Dhrs9 dehydrogenase/reductase 9 increases expression
multiple interactions
ISO fluoranthene results in increased expression of DHRS9 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of DHRS9 mRNA
CTD PMID:28329830 NCBI chr 3:55,623,671...55,645,883
Ensembl chr 3:55,623,634...55,648,325
JBrowse link
G Dhx40 DEAH-box helicase 40 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DHX40 mRNA CTD PMID:28329830 NCBI chr10:74,081,442...74,119,032
Ensembl chr10:74,080,590...74,119,032
JBrowse link
G Dip2c disco-interacting protein 2 homolog C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DIP2C mRNA CTD PMID:28329830 NCBI chr17:63,426,688...63,810,183
Ensembl chr17:63,635,086...63,808,464
JBrowse link
G Dipk1a divergent protein kinase domain 1A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DIPK1A mRNA CTD PMID:28329830 NCBI chr14:2,789,699...2,860,354
Ensembl chr14:2,789,650...2,860,333
JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DLG4 mRNA CTD PMID:28329830 NCBI chr10:56,625,845...56,655,543
Ensembl chr10:56,627,411...56,653,599
JBrowse link
G Dlx2 distal-less homeobox 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DLX2 mRNA CTD PMID:28329830 NCBI chr 3:58,180,088...58,181,971
Ensembl chr 3:58,180,088...58,181,971
JBrowse link
G Dmac2l distal membrane arm assembly complex 2 like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DMAC2L mRNA CTD PMID:28329830 NCBI chr 6:92,057,782...92,076,022
Ensembl chr 6:92,057,807...92,076,021
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DNAJB9 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DNAJB9 mRNA] CTD PMID:28329830 NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
JBrowse link
G Dnttip2 deoxynucleotidyltransferase, terminal, interacting protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DNTTIP2 mRNA CTD PMID:28329830 NCBI chr 2:225,854,618...225,867,103
Ensembl chr 2:225,854,629...225,866,357
JBrowse link
G Dot1l DOT1 like histone lysine methyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DOT1L mRNA CTD PMID:28329830 NCBI chr 7:11,786,105...11,824,742
Ensembl chr 7:11,786,105...11,824,742
JBrowse link
G Dthd1 death domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DTHD1 mRNA CTD PMID:28329830 NCBI chr14:48,612,893...48,677,023
Ensembl chr14:48,629,983...48,676,829
JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions EXP
ISO
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of DUSP1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP1 mRNA
CTD PMID:18711122, PMID:28329830 NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
JBrowse link
G Dusp16 dual specificity phosphatase 16 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP16 mRNA CTD PMID:28329830 NCBI chr 4:168,470,141...168,551,346
Ensembl chr 4:168,472,412...168,517,177
JBrowse link
G Dusp4 dual specificity phosphatase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP4 mRNA CTD PMID:28329830 NCBI chr16:61,080,767...61,090,973
Ensembl chr16:61,078,175...61,091,169
JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA] CTD PMID:28329830 NCBI chr 1:274,245,184...274,258,595
Ensembl chr 1:274,245,184...274,258,595
JBrowse link
G Dusp6 dual specificity phosphatase 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP6 mRNA CTD PMID:28329830 NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
JBrowse link
G Dusp8 dual specificity phosphatase 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP8 mRNA CTD PMID:28329830 NCBI chr 1:215,030,429...215,043,111
Ensembl chr 1:215,030,429...215,033,460
JBrowse link
G E2f8 E2F transcription factor 8 decreases expression ISO fluoranthene results in decreased expression of E2F8 mRNA CTD PMID:28329830 NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591
JBrowse link
G Ece1 endothelin converting enzyme 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ECE1 mRNA CTD PMID:17690111 NCBI chr 5:156,215,469...156,318,652
Ensembl chr 5:156,215,417...156,318,671
JBrowse link
G Edn1 endothelin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EDN1 mRNA CTD PMID:28329830 NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
JBrowse link
G Eea1 early endosome antigen 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EEA1 mRNA CTD PMID:28329830 NCBI chr 7:37,101,415...37,186,534
Ensembl chr 7:37,018,459...37,186,732
JBrowse link
G Efna2 ephrin A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EFNA2 mRNA CTD PMID:28329830 NCBI chr 7:12,382,636...12,393,266
Ensembl chr 7:12,382,636...12,393,266
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EGFR mRNA CTD PMID:28329830 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EGLN1 mRNA CTD PMID:28329830 NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
JBrowse link
G Egr1 early growth response 1 increases expression
multiple interactions
ISO fluoranthene results in increased expression of EGR1 mRNA; fluoranthene results in increased expression of EGR1 protein
[1-methylanthracene co-treated with fluoranthene] results in increased expression of EGR1 mRNA
CTD PMID:15342960, PMID:28329830, PMID:29787794 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EGR2 mRNA CTD PMID:28329830 NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
JBrowse link
G Ehd2 EH-domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EHD2 mRNA CTD PMID:28329830 NCBI chr 1:77,847,599...77,865,870
Ensembl chr 1:77,847,600...77,865,870
JBrowse link
G Ehd3 EH-domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EHD3 mRNA CTD PMID:28329830 NCBI chr 6:25,076,012...25,102,457
Ensembl chr 6:25,074,955...25,100,977
JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of EHHADH mRNA CTD PMID:18711122 NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EI24 mRNA CTD PMID:28329830 NCBI chr 8:39,254,883...39,271,238
Ensembl chr 8:39,254,889...39,266,959
JBrowse link
G Eid1 EP300 interacting inhibitor of differentiation 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EID1 mRNA CTD PMID:28329830 NCBI chr 3:117,938,500...117,940,219
Ensembl chr 3:117,938,500...117,940,219
JBrowse link
G Eid3 EP300 interacting inhibitor of differentiation 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EID3 mRNA CTD PMID:28329830 NCBI chr 7:26,976,154...26,977,479 JBrowse link
G Eif1a eukaryotic translation initiation factor 1A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EIF1A mRNA CTD PMID:28329830 NCBI chr18:40,586,315...40,598,661
Ensembl chr18:40,586,315...40,597,671
JBrowse link
G Eif1b eukaryotic translation initiation factor 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EIF1B mRNA CTD PMID:28329830 NCBI chr 8:129,158,112...129,160,726
Ensembl chr 8:129,158,103...129,160,757
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EIF2AK3 mRNA CTD PMID:28329830 NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
JBrowse link
G Elof1 elongation factor 1 homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOF1 mRNA CTD PMID:28329830 NCBI chr 8:23,125,987...23,130,980
Ensembl chr 8:23,125,988...23,130,877
JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOVL1 mRNA CTD PMID:28329830 NCBI chr 5:137,255,868...137,260,486
Ensembl chr 5:137,255,908...137,260,483
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOVL6 mRNA
fluoranthene results in decreased expression of ELOVL6 mRNA
CTD PMID:28329830 NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145
Ensembl chr 2:234,189,105...234,296,145
JBrowse link
G Emx2 empty spiracles homeobox 2 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EMX2 mRNA
fluoranthene results in decreased expression of EMX2 mRNA
CTD PMID:28329830 NCBI chr 1:280,633,938...280,640,946
Ensembl chr 1:280,633,938...280,640,946
JBrowse link
G Enc1 ectodermal-neural cortex 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA] CTD PMID:28329830 NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
JBrowse link
G Epc1 enhancer of polycomb homolog 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPC1 mRNA CTD PMID:28329830 NCBI chr17:57,303,968...57,394,975
Ensembl chr17:57,304,933...57,394,985
JBrowse link
G Epc2 enhancer of polycomb homolog 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPC2 mRNA CTD PMID:28329830 NCBI chr 3:33,641,616...33,741,219
Ensembl chr 3:33,641,616...33,740,461
JBrowse link
G Epha2 Eph receptor A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPHA2 mRNA CTD PMID:28329830 NCBI chr 5:159,845,773...159,874,203
Ensembl chr 5:159,845,774...159,874,206
JBrowse link
G Ereg epiregulin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EREG mRNA CTD PMID:28329830 NCBI chr14:18,577,620...18,591,395
Ensembl chr14:18,576,355...18,591,394
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ERN1 mRNA CTD PMID:28329830 NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ERRFI1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of ERRFI1 mRNA] CTD PMID:28329830 NCBI chr 5:167,951,564...167,966,011
Ensembl chr 5:167,952,728...167,966,009
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
decreases expression
ISO
EXP
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; fluoranthene promotes the reaction [Estradiol results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [fluoranthene promotes the reaction [Estradiol results in increased activity of ESR1 protein]]
fluoranthene results in decreased expression of ESR1 protein
CTD PMID:12441364, PMID:18634860, PMID:30980910 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Ets2 ETS proto-oncogene 2, transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ETS2 mRNA CTD PMID:28329830 NCBI chr11:36,075,709...36,092,495
Ensembl chr11:36,075,709...36,092,495
JBrowse link
G Etv5 ETS variant transcription factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ETV5 mRNA CTD PMID:28329830 NCBI chr11:82,194,657...82,252,145
Ensembl chr11:82,194,657...82,252,139
JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of F3 mRNA CTD PMID:28329830 NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
JBrowse link
G Fabp1 fatty acid binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of FABP1 mRNA CTD PMID:17690111 NCBI chr 4:99,063,181...99,066,957
Ensembl chr 4:99,063,181...99,066,954
JBrowse link
G Fam102a family with sequence similarity 102, member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM102A mRNA CTD PMID:28329830 NCBI chr 3:11,554,084...11,586,315
Ensembl chr 3:11,554,457...11,586,303
JBrowse link
G Fam110c family with sequence similarity 110, member C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FAM110C mRNA CTD PMID:28329830 NCBI chr 6:49,968,473...49,974,730
Ensembl chr 6:49,968,473...49,974,728
JBrowse link
G Fam118a family with sequence similarity 118, member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FAM118A mRNA CTD PMID:28329830 NCBI chr 7:125,937,928...125,964,455
Ensembl chr 7:125,937,928...125,964,453
JBrowse link
G Fam136a family with sequence similarity 136, member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM136A mRNA CTD PMID:28329830 NCBI chr 4:118,160,147...118,166,062
Ensembl chr 4:118,160,147...118,166,062
JBrowse link
G Fam13b family with sequence similarity 13, member B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FAM13B mRNA CTD PMID:28329830 NCBI chr18:27,223,345...27,304,462
Ensembl chr18:27,223,345...27,289,876
JBrowse link
G Fam149a family with sequence similarity 149, member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM149A mRNA CTD PMID:28329830 NCBI chr16:50,049,816...50,105,962
Ensembl chr16:50,049,828...50,107,856
JBrowse link
G Fam162a family with sequence similarity 162, member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM162A mRNA CTD PMID:28329830 NCBI chr11:67,618,683...67,646,253
Ensembl chr11:67,618,625...67,646,253
JBrowse link
G Fam189b family with sequence similarity 189, member B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM189B mRNA CTD PMID:28329830 NCBI chr 2:188,495,237...188,501,444
Ensembl chr 2:188,495,629...188,501,444
JBrowse link
G Fam83h family with sequence similarity 83, member H multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM83H mRNA CTD PMID:28329830 NCBI chr 7:117,062,748...117,070,936
Ensembl chr 7:117,062,692...117,070,936
JBrowse link
G Fbxo32 F-box protein 32 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO32 mRNA CTD PMID:28329830 NCBI chr 7:98,065,664...98,098,071
Ensembl chr 7:98,063,735...98,098,268
JBrowse link
G Fbxo33 F-box protein 33 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO33 mRNA CTD PMID:28329830 NCBI chr 6:80,302,291...80,334,536
Ensembl chr 6:80,302,303...80,334,522
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of FDFT1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FDFT1 mRNA
CTD PMID:28329830 NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
JBrowse link
G Fdps farnesyl diphosphate synthase multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FDPS mRNA
fluoranthene results in decreased expression of FDPS mRNA
CTD PMID:28329830 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fgd6 FYVE, RhoGEF and PH domain containing 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGD6 mRNA CTD PMID:28329830 NCBI chr 7:34,951,878...35,063,006
Ensembl chr 7:34,952,011...35,063,929
JBrowse link
G Fgf18 fibroblast growth factor 18 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of FGF18 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FGF18 mRNA
CTD PMID:28329830 NCBI chr10:18,047,109...18,082,290
Ensembl chr10:18,047,109...18,063,391
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF2 mRNA CTD PMID:28329830 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
JBrowse link
G Fgf21 fibroblast growth factor 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF21 mRNA CTD PMID:28329830 NCBI chr 1:101,595,579...101,596,822
Ensembl chr 1:101,595,579...101,596,822
JBrowse link
G Fgf5 fibroblast growth factor 5 increases expression
multiple interactions
ISO fluoranthene results in increased expression of FGF5 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF5 mRNA
CTD PMID:28329830 NCBI chr14:12,974,921...12,996,046
Ensembl chr14:12,974,921...12,995,584
JBrowse link
G Fgf7 fibroblast growth factor 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA] CTD PMID:28329830 NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872
JBrowse link
G Fn3krp fructosamine-3-kinase-related protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FN3KRP mRNA CTD PMID:28329830 NCBI chr10:110,614,739...110,622,625
Ensembl chr10:110,614,713...110,623,519
JBrowse link
G Fnip2 folliculin interacting protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FNIP2 mRNA CTD PMID:28329830 NCBI chr 2:178,223,561...178,334,925
Ensembl chr 2:178,225,915...178,334,900
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOS mRNA CTD PMID:28329830 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL1 mRNA] CTD PMID:28329830 NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL2 mRNA CTD PMID:28329830 NCBI chr 6:25,598,936...25,616,995
Ensembl chr 6:25,598,936...25,616,995
JBrowse link
G Foxf2 forkhead box F2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOXF2 mRNA CTD PMID:28329830 NCBI chr17:34,150,417...34,156,450 JBrowse link
G Foxj3 forkhead box J3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOXJ3 mRNA CTD PMID:28329830 NCBI chr 5:138,587,968...138,676,948
Ensembl chr 5:138,605,793...138,676,962
JBrowse link
G Foxo6 forkhead box O6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOXO6 mRNA CTD PMID:28329830 NCBI chr 5:139,208,153...139,227,288
Ensembl chr 5:139,208,046...139,227,196
JBrowse link
G Fst follistatin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FST mRNA CTD PMID:28329830 NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
JBrowse link
G Fut11 fucosyltransferase 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FUT11 mRNA CTD PMID:28329830 NCBI chr15:4,031,504...4,035,064
Ensembl chr15:4,031,504...4,035,064
JBrowse link
G Fzd2 frizzled class receptor 2 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of FZD2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FZD2 mRNA
CTD PMID:28329830 NCBI chr10:90,550,147...90,552,057
Ensembl chr10:90,550,147...90,552,057
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of G6PD mRNA CTD PMID:17690111 NCBI chr  X:156,274,800...156,293,935
Ensembl chr  X:156,274,800...156,293,926
JBrowse link
G Gab2 GRB2-associated binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GAB2 mRNA CTD PMID:28329830 NCBI chr 1:162,082,876...162,283,379
Ensembl chr 1:162,083,030...162,279,727
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45A mRNA CTD PMID:28329830 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45B mRNA CTD PMID:28329830 NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of GADD45G mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of GADD45G mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45G mRNA
CTD PMID:28329830 NCBI chr17:13,391,474...13,393,219
Ensembl chr17:13,391,467...13,393,243
JBrowse link
G Galnt12 polypeptide N-acetylgalactosaminyltransferase 12 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GALNT12 mRNA CTD PMID:28329830 NCBI chr 5:62,718,733...62,751,345
Ensembl chr 5:62,718,787...62,750,145
JBrowse link
G Gata2 GATA binding protein 2 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of GATA2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of GATA2 mRNA
CTD PMID:28329830 NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
JBrowse link
G Gata4 GATA binding protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GATA4 mRNA CTD PMID:28329830 NCBI chr15:46,386,703...46,458,679
Ensembl chr15:46,386,712...46,432,965
JBrowse link
G Gch1 GTP cyclohydrolase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GCH1 mRNA CTD PMID:28329830 NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
JBrowse link
G Gck glucokinase multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of GCK mRNA CTD PMID:17690111 NCBI chr14:86,149,146...86,191,589
Ensembl chr14:86,148,928...86,190,659
JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GDNF mRNA
fluoranthene results in increased expression of GDNF mRNA
CTD PMID:28329830 NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
JBrowse link
G Gdpgp1 GDP-D-glucose phosphorylase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GDPGP1 mRNA CTD PMID:28329830 NCBI chr 1:142,020,696...142,028,775 JBrowse link
G Gfod1 glucose-fructose oxidoreductase domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GFOD1 mRNA CTD PMID:28329830 NCBI chr17:23,818,370...23,924,393
Ensembl chr17:23,823,632...23,923,792
JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions
decreases expression
decreases localization
ISO [1-methylanthracene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in decreased expression of GJA1 mRNA; [1-methylanthracene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in decreased expression of GJA1 protein; [1-methylanthracene co-treated with fluoranthene] results in increased degradation of and results in decreased expression of GJA1 protein; fluoranthene results in increased degradation of and results in decreased expression of GJA1 protein
fluoranthene results in decreased expression of GJA1 protein
fluoranthene results in decreased localization of GJA1 protein
CTD PMID:28329830, PMID:29170806, PMID:30668803 NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
JBrowse link
G Gjb1 gap junction protein, beta 1 decreases expression
multiple interactions
EXP
ISO
fluoranthene results in decreased expression of GJB1 protein
[1-methylanthracene co-treated with fluoranthene] affects the expression of and affects the activity of GJB1 protein; fluoranthene affects the expression of and affects the activity of GJB1 protein; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] affects the expression of and affects the activity of GJB1 protein]; SB 203580 inhibits the reaction [fluoranthene affects the expression of and affects the activity of GJB1 protein]
CTD PMID:25268939, PMID:28329830 NCBI chr  X:71,272,030...71,279,973
Ensembl chr  X:71,272,042...71,279,977
JBrowse link
G Glis2 GLIS family zinc finger 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GLIS2 mRNA CTD PMID:28329830 NCBI chr10:11,154,459...11,177,063
Ensembl chr10:11,154,658...11,174,861
JBrowse link
G Glrx glutaredoxin decreases expression ISO fluoranthene results in decreased expression of GLRX mRNA CTD PMID:28329830 NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
JBrowse link
G Glrx5 glutaredoxin 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GLRX5 mRNA CTD PMID:28329830 NCBI chr 6:128,750,503...128,760,880
Ensembl chr 6:128,750,795...128,760,880
JBrowse link
G Gnb4 G protein subunit beta 4 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GNB4 mRNA
fluoranthene results in increased expression of GNB4 mRNA
CTD PMID:28329830 NCBI chr 2:118,978,965...119,007,877
Ensembl chr 2:118,978,973...119,007,835
JBrowse link
G Gnl3 G protein nucleolar 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GNL3 mRNA CTD PMID:28329830 NCBI chr16:7,097,580...7,103,518
Ensembl chr16:7,097,507...7,103,604
JBrowse link
G Golga5 golgin A5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GOLGA5 mRNA CTD PMID:28329830 NCBI chr 6:126,350,572...126,378,735
Ensembl chr 6:126,353,223...126,378,610
JBrowse link
G Gorab golgin, RAB6-interacting multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GORAB mRNA CTD PMID:28329830 NCBI chr13:81,682,207...81,698,827
Ensembl chr13:81,682,018...81,698,833
JBrowse link
G Gpatch11 G patch domain containing 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GPATCH11 mRNA CTD PMID:28329830 NCBI chr 6:1,410,461...1,421,506
Ensembl chr 6:1,410,507...1,423,041
JBrowse link
G Gpd1l glycerol-3-phosphate dehydrogenase 1-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GPD1L mRNA CTD PMID:28329830 NCBI chr 8:122,957,570...122,987,236
Ensembl chr 8:122,954,948...122,987,191
JBrowse link
G Gramd1b GRAM domain containing 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GRAMD1B mRNA CTD PMID:28329830 NCBI chr 8:44,160,634...44,399,110
Ensembl chr 8:44,165,367...44,327,551
JBrowse link
G Gramd4 GRAM domain containing 4 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GRAMD4 mRNA
fluoranthene results in increased expression of GRAMD4 mRNA
CTD PMID:28329830 NCBI chr 7:126,939,819...127,013,455
Ensembl chr 7:126,939,925...127,013,486
JBrowse link
G Gsdme gasdermin E increases expression ISO fluoranthene results in increased expression of GSDME mRNA CTD PMID:28329830 NCBI chr 4:79,934,075...79,999,678
Ensembl chr 4:79,934,887...79,989,572
JBrowse link
G Gtpbp2 GTP binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GTPBP2 mRNA CTD PMID:28329830 NCBI chr 9:17,198,957...17,208,456
Ensembl chr 9:17,198,957...17,209,220
JBrowse link
G Gtpbp4 GTP binding protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GTPBP4 mRNA CTD PMID:28329830 NCBI chr17:63,111,086...63,145,618
Ensembl chr17:63,110,254...63,145,577
JBrowse link
G Gys1 glycogen synthase 1 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GYS1 mRNA
fluoranthene results in decreased expression of GYS1 mRNA
CTD PMID:28329830 NCBI chr 1:101,427,195...101,447,092
Ensembl chr 1:101,427,195...101,447,092
JBrowse link
G H1f2 H1.2 linker histone, cluster member decreases expression ISO fluoranthene results in decreased expression of H1F2 mRNA CTD PMID:28329830 NCBI chr17:43,638,938...43,640,445
Ensembl chr17:43,639,749...43,640,387
JBrowse link
G H2ac20 H2A clustered histone 20 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of H2AC20 mRNA CTD PMID:28329830 NCBI chr 2:198,360,271...198,360,735
Ensembl chr 2:198,360,301...198,360,678
JBrowse link
G H2ax H2A.X variant histone multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of H2AX mRNA CTD PMID:28329830 NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
JBrowse link
G Hacd4 3-hydroxyacyl-CoA dehydratase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HACD4 mRNA CTD PMID:28329830 NCBI chr 5:106,728,401...106,758,068
Ensembl chr 5:106,732,513...106,758,032
JBrowse link
G Has2 hyaluronan synthase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA] CTD PMID:28329830 NCBI chr 7:96,438,046...96,464,049
Ensembl chr 7:96,438,046...96,464,049
JBrowse link
G Hbegf heparin-binding EGF-like growth factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HBEGF mRNA CTD PMID:28329830 NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
JBrowse link
G Hcfc1r1 host cell factor C1 regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HCFC1R1 mRNA CTD PMID:28329830 NCBI chr10:12,994,229...12,995,674
Ensembl chr10:12,994,683...12,995,457
JBrowse link
G Hcn2 hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HCN2 mRNA CTD PMID:28329830 NCBI chr 7:12,851,730...12,870,087
Ensembl chr 7:12,851,739...12,874,215
JBrowse link
G Hdac4 histone deacetylase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HDAC4 mRNA CTD PMID:28329830 NCBI chr 9:99,052,945...99,299,715
Ensembl chr 9:99,057,089...99,299,715
JBrowse link
G Hddc2 HD domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HDDC2 mRNA CTD PMID:28329830 NCBI chr 1:28,567,447...28,600,116
Ensembl chr 1:28,579,990...28,600,586
JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HERPUD1 mRNA CTD PMID:28329830 NCBI chr19:11,046,905...11,057,440
Ensembl chr19:11,046,909...11,057,254
JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HES1 mRNA CTD PMID:28329830 NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248
JBrowse link
G Hgsnat heparan-alpha-glucosaminide N-acetyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HGSNAT mRNA CTD PMID:28329830 NCBI chr16:70,876,557...70,909,443 JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of HIF1A mRNA CTD PMID:17690111 NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
JBrowse link
G Higd1a HIG1 hypoxia inducible domain family, member 1A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HIGD1A mRNA CTD PMID:28329830 NCBI chr 8:130,482,492...130,491,888
Ensembl chr 8:130,482,493...130,491,998
JBrowse link
G Hinfp histone H4 transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HINFP mRNA CTD PMID:28329830 NCBI chr 8:48,626,398...48,638,012
Ensembl chr 8:48,628,340...48,634,797
JBrowse link
G Hivep2 HIVEP zinc finger 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HIVEP2 mRNA CTD PMID:28329830 NCBI chr 1:8,129,354...8,333,890
Ensembl chr 1:8,310,577...8,333,885
JBrowse link
G Hmga2 high mobility group AT-hook 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA] CTD PMID:28329830 NCBI chr 7:65,159,944...65,275,408
Ensembl chr 7:65,159,944...65,275,408
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of HMGCR mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of HMGCR mRNA
CTD PMID:28329830 NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HMGCS1 mRNA
fluoranthene results in decreased expression of HMGCS1 mRNA
CTD PMID:28329830 NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HMOX1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMOX1 mRNA] CTD PMID:28329830 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hs6st1 heparan sulfate 6-O-sulfotransferase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HS6ST1 mRNA CTD PMID:28329830 NCBI chr 9:42,620,006...42,659,184
Ensembl chr 9:42,620,006...42,659,184
JBrowse link
G Hsbp1 heat shock factor binding protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HSBP1 mRNA CTD PMID:28329830 NCBI chr19:51,985,196...51,989,528
Ensembl chr19:51,985,170...51,989,544
JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of HSD11B1 mRNA CTD PMID:18711122 NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
JBrowse link
G Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HSD17B7 mRNA
fluoranthene results in decreased expression of HSD17B7 mRNA
CTD PMID:28329830 NCBI chr13:88,288,116...88,308,019
Ensembl chr13:88,288,046...88,307,988
JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA] CTD PMID:28329830 NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA5 mRNA CTD PMID:28329830 NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression ISO fluoranthene results in increased expression of ICAM1 protein CTD PMID:22313677 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
JBrowse link
G Id1 inhibitor of DNA binding 1, HLH protein multiple interactions
decreases expression
EXP
ISO
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ID1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ID1 mRNA
fluoranthene results in decreased expression of ID1 mRNA
CTD PMID:18711122, PMID:28329830 NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IDH1 mRNA CTD PMID:28329830 NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of IDI1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of IDI1 mRNA
CTD PMID:28329830 NCBI chr17:57,976,266...57,984,036
Ensembl chr17:57,976,268...57,984,036
JBrowse link
G Ier2 immediate early response 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER2 mRNA CTD PMID:28329830 NCBI chr19:25,774,146...25,775,670
Ensembl chr19:25,774,143...25,775,659
JBrowse link
G Ier3 immediate early response 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER3 mRNA CTD PMID:28329830 NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
JBrowse link
G Ier5 immediate early response 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER5 mRNA CTD PMID:28329830 NCBI chr13:72,742,210...72,744,302
Ensembl chr13:72,742,210...72,744,303
JBrowse link
G Ifi30 IFI30, lysosomal thiol reductase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IFI30 mRNA CTD PMID:28329830 NCBI chr16:20,426,566...20,430,772
Ensembl chr16:20,426,566...20,430,752
JBrowse link
G Ifng interferon gamma increases expression ISO fluoranthene results in increased expression of IFNG mRNA CTD PMID:18434080 NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
JBrowse link
G Ifrd1 interferon-related developmental regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IFRD1 mRNA CTD PMID:28329830 NCBI chr 6:60,132,025...60,151,354
Ensembl chr 6:60,132,024...60,151,420
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of IGF1 mRNA CTD PMID:17690111 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Igsf3 immunoglobulin superfamily, member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IGSF3 mRNA CTD PMID:28329830 NCBI chr 2:203,768,364...203,855,573
Ensembl chr 2:203,768,117...203,855,573
JBrowse link
G Il12rb1 interleukin 12 receptor subunit beta 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL12RB1 mRNA CTD PMID:28329830 NCBI chr16:20,370,722...20,383,576
Ensembl chr16:20,371,338...20,383,337
JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL13RA1 mRNA CTD PMID:28329830 NCBI chr  X:122,724,081...122,783,801
Ensembl chr  X:122,724,129...122,781,479
JBrowse link
G Il13ra2 interleukin 13 receptor subunit alpha 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL13RA2 mRNA CTD PMID:28329830 NCBI chr  X:118,443,955...118,514,716
Ensembl chr  X:118,443,823...118,513,061
JBrowse link
G Il17ra interleukin 17 receptor A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL17RA mRNA CTD PMID:28329830 NCBI chr 4:152,995,865...153,018,394
Ensembl chr 4:152,995,865...153,018,394
JBrowse link
G Il22ra1 interleukin 22 receptor subunit alpha 1 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of IL22RA1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of IL22RA1 mRNA
CTD PMID:28329830 NCBI chr 5:154,078,093...154,102,903
Ensembl chr 5:154,077,944...154,106,433
JBrowse link
G Il4 interleukin 4 increases expression
multiple interactions
ISO fluoranthene results in increased expression of IL4 mRNA
TNF protein inhibits the reaction [fluoranthene results in increased expression of IL4 mRNA]
CTD PMID:18434080 NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
JBrowse link
G Il6 interleukin 6 increases expression
increases secretion
multiple interactions
ISO fluoranthene results in increased expression of IL6 mRNA
fluoranthene results in increased secretion of IL6 protein
[1-methylanthracene co-treated with fluoranthene] results in increased expression of IL6 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IL6 mRNA]
TNF protein promotes the reaction [fluoranthene results in increased expression of IL6 mRNA]
CTD PMID:18434080, PMID:28329830, PMID:29787794 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Il6r interleukin 6 receptor multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IL6RA mRNA
fluoranthene results in decreased expression of IL6RA mRNA
CTD PMID:28329830 NCBI chr 2:189,196,180...189,255,987
Ensembl chr 2:189,205,701...189,254,628
JBrowse link
G Ildr2 immunoglobulin-like domain containing receptor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ILDR2 mRNA CTD PMID:28329830 NCBI chr13:84,474,191...84,532,347
Ensembl chr13:84,474,319...84,530,031
JBrowse link
G Inka2 inka box actin regulator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of INKA2 mRNA CTD PMID:28329830 NCBI chr 2:208,170,652...208,187,088
Ensembl chr 2:208,170,652...208,185,965
JBrowse link
G Insig1 insulin induced gene 1 decreases expression ISO fluoranthene results in decreased expression of INSIG1 mRNA CTD PMID:28329830 NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
JBrowse link
G Ipo7 importin 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IPO7 mRNA CTD PMID:28329830 NCBI chr 1:174,655,939...174,696,173
Ensembl chr 1:174,655,939...174,696,173
JBrowse link
G Iqcf5 IQ motif containing F5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IQCF5 mRNA CTD PMID:28329830 NCBI chr 8:115,213,469...115,214,854
Ensembl chr 8:115,213,471...115,214,895
JBrowse link
G Irak2 interleukin-1 receptor-associated kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRAK2 mRNA CTD PMID:28329830 NCBI chr 4:145,594,575...145,651,066
Ensembl chr 4:145,594,575...145,651,053
JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF1 mRNA
fluoranthene results in increased expression of IRF1 mRNA
CTD PMID:28329830 NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
JBrowse link
G Irf2 interferon regulatory factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2 mRNA CTD PMID:28329830 NCBI chr16:48,582,354...48,732,129
Ensembl chr16:48,582,026...48,732,932
JBrowse link
G Irf2bp2 interferon regulatory factor 2 binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2BP2 mRNA CTD PMID:28329830 NCBI chr19:59,497,021...59,502,298
Ensembl chr19:59,499,876...59,502,161
JBrowse link
G Irf2bpl interferon regulatory factor 2 binding protein-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2BPL mRNA CTD PMID:28329830 NCBI chr 6:110,901,940...110,904,288
Ensembl chr 6:110,901,940...110,904,288
JBrowse link
G Irgm immunity-related GTPase M multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA] CTD PMID:28329830 NCBI chr10:34,213,885...34,221,968
Ensembl chr10:34,213,936...34,221,928
JBrowse link
G Itgb8 integrin subunit beta 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ITGB8 mRNA CTD PMID:28329830 NCBI chr 6:147,089,280...147,172,846
Ensembl chr 6:147,094,097...147,172,813
JBrowse link
G Itprip inositol 1,4,5-trisphosphate receptor interacting protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ITPRIP mRNA CTD PMID:28329830 NCBI chr 1:267,649,385...267,673,341
NCBI chr 1:271,252,447...271,272,169
Ensembl chr 1:267,651,320...267,653,389
Ensembl chr 1:267,651,320...267,653,389
JBrowse link
G Jdp2 Jun dimerization protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JDP2 mRNA CTD PMID:28329830 NCBI chr 6:109,464,910...109,505,591
Ensembl chr 6:109,466,060...109,505,161
JBrowse link
G Jmjd1c jumonji domain containing 1C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JMJD1C mRNA CTD PMID:28329830 NCBI chr20:22,751,743...22,914,080
Ensembl chr20:22,751,743...22,882,672
JBrowse link
G Jrkl JRK-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of JRKL mRNA CTD PMID:28329830 NCBI chr 8:11,884,903...11,887,799
Ensembl chr 8:11,884,903...11,887,799
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JUN mRNA CTD PMID:28329830 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JUNB mRNA CTD PMID:28329830 NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
JBrowse link
G Katnbl1 katanin regulatory subunit B1 like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KATNBL1 mRNA CTD PMID:28329830 NCBI chr 3:103,511,653...103,513,498
Ensembl chr 3:103,866,144...103,905,936
JBrowse link
G Kbtbd2 kelch repeat and BTB domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KBTBD2 mRNA CTD PMID:28329830 NCBI chr 4:87,088,759...87,111,576
Ensembl chr 4:87,088,759...87,111,025
JBrowse link
G Kctd21 potassium channel tetramerization domain containing 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KCTD21 mRNA CTD PMID:28329830 NCBI chr 1:162,307,746...162,325,284
Ensembl chr 1:162,320,730...162,325,013
JBrowse link
G Kdm5a lysine demethylase 5A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KDM5A mRNA CTD PMID:28329830 NCBI chr 4:152,892,388...152,972,196
Ensembl chr 4:152,892,388...152,972,201
JBrowse link
G Kdm7a lysine demethylase 7A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KDM7A mRNA CTD PMID:28329830 NCBI chr 4:66,915,603...66,957,971
Ensembl chr 4:66,922,013...66,955,732
JBrowse link
G Kif21b kinesin family member 21B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KIF21B mRNA CTD PMID:28329830 NCBI chr13:52,976,505...53,026,750
Ensembl chr13:52,976,507...53,023,103
JBrowse link
G Klf10 Kruppel-like factor 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF10 mRNA CTD PMID:28329830 NCBI chr 7:77,156,010...77,162,096
Ensembl chr 7:77,156,006...77,162,148
JBrowse link
G Klf4 Kruppel like factor 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA] CTD PMID:28329830 NCBI chr 5:72,283,311...72,287,669
Ensembl chr 5:72,283,313...72,287,669
JBrowse link
G Klf5 Kruppel-like factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA] CTD PMID:28329830 NCBI chr15:83,703,796...83,722,921
Ensembl chr15:83,703,791...83,722,921
JBrowse link
G Klf6 Kruppel-like factor 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF6 mRNA CTD PMID:28329830 NCBI chr17:67,887,939...67,945,052
Ensembl chr17:67,887,939...67,945,037
JBrowse link
G Klf9 Kruppel-like factor 9 increases expression
multiple interactions
ISO fluoranthene results in increased expression of KLF9 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF9 mRNA
CTD PMID:28329830 NCBI chr 1:240,908,483...240,933,198
Ensembl chr 1:240,908,483...240,933,198
JBrowse link
G Klhl21 kelch-like family member 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLHL21 mRNA CTD PMID:28329830 NCBI chr 5:169,181,418...169,190,073
Ensembl chr 5:169,181,418...169,190,073
JBrowse link
G Klhl42 kelch-like family, member 42 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KLHL42 mRNA CTD PMID:28329830 NCBI chr 4:181,481,147...181,502,916
Ensembl chr 4:181,481,147...181,502,916
JBrowse link
G Kpna2 karyopherin subunit alpha 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KPNA2 mRNA CTD PMID:28329830 NCBI chr10:95,200,029...95,212,111
Ensembl chr10:95,200,030...95,212,111
JBrowse link
G Kyat3 kynurenine aminotransferase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KYAT3 mRNA CTD PMID:28329830 NCBI chr 2:248,644,473...248,690,289
Ensembl chr 2:248,649,441...248,690,089
JBrowse link
G L2hgdh L-2-hydroxyglutarate dehydrogenase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of L2HGDH mRNA CTD PMID:28329830 NCBI chr 6:92,016,560...92,057,643
Ensembl chr 6:92,016,622...92,057,816
JBrowse link
G Lbp lipopolysaccharide binding protein multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of LBP mRNA CTD PMID:18711122 NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
JBrowse link
G Ldha lactate dehydrogenase A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LDHA mRNA CTD PMID:28329830 NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LDLR mRNA
fluoranthene results in decreased expression of LDLR mRNA
CTD PMID:28329830 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
JBrowse link
G Leng8 leukocyte receptor cluster member 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LENG8 mRNA CTD PMID:28329830 NCBI chr 1:73,722,088...73,734,459
Ensembl chr 1:73,722,088...73,733,788
JBrowse link
G Leprot leptin receptor overlapping transcript multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LEPROT mRNA CTD PMID:28329830 NCBI chr 5:120,498,910...120,511,011
Ensembl chr 5:120,498,883...120,511,017
JBrowse link
G Lfng LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LFNG mRNA CTD PMID:28329830 NCBI chr12:16,117,767...16,126,211
Ensembl chr12:16,118,634...16,126,953
JBrowse link
G Lgals9 galectin 9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LGALS9 mRNA CTD PMID:28329830 NCBI chr10:64,737,022...64,760,195
Ensembl chr10:64,737,022...64,760,201
JBrowse link
G Lif LIF, interleukin 6 family cytokine multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LIF mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of LIF mRNA] CTD PMID:28329830 NCBI chr14:84,482,652...84,500,574
Ensembl chr14:84,482,674...84,500,642
JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LMCD1 mRNA CTD PMID:28329830 NCBI chr 4:144,192,989...144,252,554
Ensembl chr 4:144,192,989...144,252,551
JBrowse link
G Lmln leishmanolysin like peptidase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LMLN mRNA CTD PMID:28329830 NCBI chr11:70,895,141...70,963,121
Ensembl chr11:70,897,052...70,961,358
JBrowse link
G Lmnb1 lamin B1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LMNB1 mRNA CTD PMID:28329830 NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
JBrowse link
G Lmo4 LIM domain only 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LMO4 mRNA CTD PMID:28329830 NCBI chr 2:250,218,635...250,235,435
Ensembl chr 2:250,218,641...250,241,673
JBrowse link
G LOC100909712 cyclin-L1-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCNL1 mRNA CTD PMID:28329830 NCBI chr 2:157,759,898...157,763,422
Ensembl chr 2:157,747,542...157,759,838
JBrowse link
G LOC100909795 colorectal mutant cancer protein-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MCC mRNA CTD PMID:28329830 NCBI chr18:78,550,661...78,577,178 JBrowse link
G LOC103689943 meiosis arrest female protein 1-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MARF1 mRNA CTD PMID:28329830 NCBI chr10:28,267...72,912
Ensembl chr10:28,243...72,912
JBrowse link
G LOC103689977 caspase-6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CASP6 mRNA CTD PMID:28329830 NCBI chr 2:230,186,170...230,198,555
Ensembl chr 2:230,186,198...230,198,555
JBrowse link
G LOC103692719 tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRMT61A mRNA CTD PMID:28329830 NCBI chr 6:136,244,466...136,250,496
Ensembl chr 6:136,150,785...136,250,752
JBrowse link
G LOC362863 first gene upstream of Nt5dc3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NT5DC3 mRNA CTD PMID:28329830 NCBI chr 7:27,248,115...27,307,601
Ensembl chr 7:27,240,876...27,307,580
JBrowse link
G Lpcat3 lysophosphatidylcholine acyltransferase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LPCAT3 mRNA CTD PMID:28329830 NCBI chr 4:157,181,722...157,222,997
Ensembl chr 4:157,181,795...157,222,996
JBrowse link
G Lpin1 lipin 1 decreases expression ISO fluoranthene results in decreased expression of LPIN1 mRNA CTD PMID:28329830 NCBI chr 6:41,796,214...41,905,149
Ensembl chr 6:41,799,749...41,870,046
JBrowse link
G Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRIG1 mRNA CTD PMID:28329830 NCBI chr 4:126,615,998...126,717,434
Ensembl chr 4:126,617,244...126,644,895
JBrowse link
G Lrrc2 leucine rich repeat containing 2 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC2 mRNA
fluoranthene results in increased expression of LRRC2 mRNA
CTD PMID:28329830 NCBI chr 8:119,226,651...119,259,649
Ensembl chr 8:119,228,612...119,259,645
JBrowse link
G Lrrc8c leucine rich repeat containing 8 VRAC subunit C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC8C mRNA CTD PMID:28329830 NCBI chr14:5,283,655...5,378,738
Ensembl chr14:5,283,647...5,378,726
JBrowse link
G Lrrc8d leucine rich repeat containing 8 VRAC subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC8D mRNA CTD PMID:28329830 NCBI chr14:5,085,606...5,194,808
Ensembl chr14:5,086,054...5,101,177
JBrowse link
G Lss lanosterol synthase decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of LSS mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of LSS mRNA
CTD PMID:28329830 NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
JBrowse link
G Lurap1l leucine rich adaptor protein 1-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LURAP1L mRNA CTD PMID:28329830 NCBI chr 5:98,468,039...98,515,126
Ensembl chr 5:98,469,047...98,515,125
JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LY96 mRNA CTD PMID:28329830 NCBI chr 5:1,972,212...1,989,448 JBrowse link
G Lysmd3 LysM domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LYSMD3 mRNA CTD PMID:28329830 NCBI chr 2:9,526,213...9,532,370
Ensembl chr 2:9,526,209...9,534,362
JBrowse link
G Lyst lysosomal trafficking regulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LYST mRNA CTD PMID:28329830 NCBI chr17:90,323,055...90,522,091 JBrowse link
G Maf MAF bZIP transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAF mRNA CTD PMID:28329830 NCBI chr19:48,179,826...48,200,995
Ensembl chr19:48,194,804...48,196,748
JBrowse link
G Maff MAF bZIP transcription factor F multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAFF mRNA CTD PMID:28329830 NCBI chr 7:120,580,743...120,592,095
Ensembl chr 7:120,580,743...120,592,095
JBrowse link
G Mafk MAF bZIP transcription factor K multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAFK mRNA CTD PMID:28329830 NCBI chr12:16,923,989...16,934,706
Ensembl chr12:16,923,990...16,934,706
JBrowse link
G Map3k2 mitogen activated protein kinase kinase kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAP3K2 mRNA CTD PMID:28329830 NCBI chr18:24,961,250...25,025,488
Ensembl chr18:24,961,245...25,025,897
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of MAPK1 protein; fluoranthene results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:28329830 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of MAPK3 protein; fluoranthene results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:28329830 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Marf1 meiosis regulator and mRNA stability factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MARF1 mRNA CTD PMID:28329830 NCBI chr10:908,806...953,481
Ensembl chr10:908,806...953,474
JBrowse link
G Marveld1 MARVEL domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MARVELD1 mRNA CTD PMID:28329830 NCBI chr 1:261,389,804...261,393,736
Ensembl chr 1:261,389,804...261,393,736
JBrowse link
G Mast4 microtubule associated serine/threonine kinase family member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAST4 mRNA CTD PMID:28329830 NCBI chr 2:32,442,285...32,519,052
Ensembl chr 2:32,859,856...33,025,271
Ensembl chr 2:32,859,856...33,025,271
JBrowse link
G Mblac2 metallo-beta-lactamase domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MBLAC2 mRNA CTD PMID:28329830 NCBI chr 2:9,578,501...9,621,297
Ensembl chr 2:9,578,345...9,623,513
JBrowse link
G Mboat1 membrane bound O-acyltransferase domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MBOAT1 mRNA CTD PMID:28329830 NCBI chr17:36,061,775...36,177,457
Ensembl chr17:36,061,775...36,177,457
JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of MDM2 mRNA CTD PMID:17690111 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
JBrowse link
G Me1 malic enzyme 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ME1 mRNA CTD PMID:18711122 NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
JBrowse link
G Med13l mediator complex subunit 13L multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MED13L mRNA CTD PMID:28329830 NCBI chr12:43,421,317...43,576,859
Ensembl chr12:43,421,308...43,576,804
JBrowse link
G Medag mesenteric estrogen-dependent adipogenesis multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEDAG mRNA CTD PMID:28329830 NCBI chr12:6,711,745...6,730,959
Ensembl chr12:6,711,747...6,740,714
JBrowse link
G Mef2d myocyte enhancer factor 2D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MEF2D mRNA CTD PMID:28329830 NCBI chr 2:187,511,775...187,541,285
Ensembl chr 2:187,512,164...187,538,026
JBrowse link
G Meis2 Meis homeobox 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEIS2 mRNA CTD PMID:28329830 NCBI chr 3:107,560,172...107,762,732
Ensembl chr 3:107,559,997...107,760,589
JBrowse link
G Mfsd9 major facilitator superfamily domain containing 9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MFSD9 mRNA CTD PMID:28329830 NCBI chr 9:47,496,977...47,516,474
Ensembl chr 9:47,496,984...47,516,460
JBrowse link
G Mia2 MIA SH3 domain ER export factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIA2 mRNA CTD PMID:28329830 NCBI chr 6:80,188,721...80,286,918
Ensembl chr 6:80,218,880...80,286,546
JBrowse link
G Mideas mitotic deacetylase associated SANT domain protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIDEAS mRNA CTD PMID:28329830 NCBI chr 6:107,633,762...107,703,462
Ensembl chr 6:107,633,716...107,678,156
JBrowse link
G Mir155 microRNA 155 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIR155 mRNA CTD PMID:28329830 NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
JBrowse link
G Mir22 microRNA 22 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MIR22 mRNA CTD PMID:28329830 NCBI chr10:62,299,592...62,299,686
Ensembl chr10:62,299,592...62,299,686
JBrowse link
G Mmab metabolism of cobalamin associated B multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MMAB mRNA
fluoranthene results in decreased expression of MMAB mRNA
CTD PMID:28329830 NCBI chr12:47,920,712...47,935,438
Ensembl chr12:47,920,743...47,935,525
JBrowse link
G Mmd monocyte to macrophage differentiation-associated multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMD mRNA CTD PMID:28329830 NCBI chr10:77,687,964...77,783,737
Ensembl chr10:77,755,216...77,783,779
JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP10 mRNA CTD PMID:28329830 NCBI chr 8:5,734,348...5,742,243
Ensembl chr 8:5,734,348...5,742,243
JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP13 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP13 mRNA] CTD PMID:28329830 NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
JBrowse link
G Mmp28 matrix metallopeptidase 28 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MMP28 mRNA CTD PMID:28329830 NCBI chr10:70,660,691...70,681,672
Ensembl chr10:70,660,691...70,681,672
JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP3 mRNA CTD PMID:28329830 NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
JBrowse link
G Mnda myeloid cell nuclear differentiation antigen multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IFI204 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of MNDA mRNA
CTD PMID:28329830 NCBI chr13:92,073,664...92,091,335
Ensembl chr13:92,073,668...92,089,980
JBrowse link
G Mnt MAX network transcriptional repressor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MNT mRNA CTD PMID:28329830 NCBI chr10:61,683,776...61,700,504
Ensembl chr10:61,685,241...61,700,491
JBrowse link
G Mospd3 motile sperm domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MOSPD3 mRNA CTD PMID:28329830 NCBI chr12:22,164,978...22,169,251
Ensembl chr12:22,165,486...22,169,241
JBrowse link
G Mov10 Mov10 RISC complex RNA helicase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MOV10 mRNA CTD PMID:28329830 NCBI chr 2:207,277,088...207,301,245
Ensembl chr 2:207,278,161...207,300,854
JBrowse link
G Mpp2 membrane palmitoylated protein 2 increases expression
multiple interactions
ISO fluoranthene results in increased expression of MPP2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of MPP2 mRNA
CTD PMID:28329830 NCBI chr10:89,998,284...90,030,766
Ensembl chr10:89,999,917...90,030,639
JBrowse link
G Mpv17l2 MPV17 mitochondrial inner membrane protein like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MPV17L2 mRNA CTD PMID:28329830 NCBI chr16:20,432,734...20,435,125
Ensembl chr16:20,432,899...20,435,974
JBrowse link
G Mrpl28 mitochondrial ribosomal protein L28 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL28 mRNA CTD PMID:28329830 NCBI chr10:15,495,616...15,498,527
Ensembl chr10:15,495,684...15,498,295
JBrowse link
G Mrpl36 mitochondrial ribosomal protein L36 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL36 mRNA CTD PMID:28329830 NCBI chr 1:31,261,370...31,264,715
Ensembl chr 1:31,261,370...31,262,466
Ensembl chr 1:31,261,370...31,262,466
JBrowse link
G Mrpl51 mitochondrial ribosomal protein L51 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL51 mRNA CTD PMID:28329830 NCBI chr 4:157,705,790...157,709,452
Ensembl chr 4:157,705,790...157,708,748
JBrowse link
G Msmo1 methylsterol monooxygenase 1 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of MSMO1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MSMO1 mRNA
CTD PMID:28329830 NCBI chr16:26,859,441...26,875,880
Ensembl chr16:26,859,397...26,875,973
JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTHFD2 mRNA CTD PMID:28329830 NCBI chr 4:115,004,433...115,015,965
Ensembl chr 4:115,004,448...115,015,965
JBrowse link
G Mtmr10 myotubularin related protein 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTMR10 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of MTMR10 mRNA] CTD PMID:28329830 NCBI chr 1:125,124,743...125,175,857
Ensembl chr 1:125,124,743...125,175,857
JBrowse link
G Muc2 mucin 2, oligomeric mucus/gel-forming multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MUC2 mRNA CTD PMID:28329830 NCBI chr 1:214,663,929...214,693,197 JBrowse link
G Muc5ac mucin 5AC, oligomeric mucus/gel-forming increases expression ISO fluoranthene results in increased expression of MUC5AC mRNA; fluoranthene results in increased expression of MUC5AC protein CTD PMID:29787794 NCBI chr 1:214,725,482...214,756,653 JBrowse link
G Muc6 mucin 6, oligomeric mucus/gel-forming increases expression ISO fluoranthene results in increased expression of MUC6 mRNA CTD PMID:28329830 NCBI chr 1:214,608,453...214,630,524
Ensembl chr 1:214,608,704...214,629,938
JBrowse link
G Mvd mevalonate diphosphate decarboxylase decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of MVD mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MVD mRNA
CTD PMID:28329830 NCBI chr19:55,258,910...55,268,933
Ensembl chr19:55,258,905...55,268,951
JBrowse link
G Mvk mevalonate kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MVK mRNA CTD PMID:28329830 NCBI chr12:47,904,266...47,920,457
Ensembl chr12:47,904,719...47,919,400
JBrowse link
G Mxra7 matrix remodeling associated 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MXRA7 mRNA CTD PMID:28329830 NCBI chr10:105,743,669...105,772,038
Ensembl chr10:105,745,276...105,771,972
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MYC mRNA CTD PMID:28329830 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
JBrowse link
G Myh6 myosin heavy chain 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MYH6 mRNA CTD PMID:28329830 NCBI chr15:33,605,653...33,629,730
Ensembl chr15:33,605,654...33,629,699
JBrowse link
G Myl12b myosin light chain 12B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MYL12B mRNA CTD PMID:28329830 NCBI chr 9:119,307,168...119,321,500
Ensembl chr 9:119,307,176...119,321,500
JBrowse link
G Napepld N-acyl phosphatidylethanolamine phospholipase D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NAPEPLD mRNA CTD PMID:28329830 NCBI chr 4:9,965,323...10,004,650
Ensembl chr 4:9,966,891...10,002,247
JBrowse link
G Narf nuclear prelamin A recognition factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NARF mRNA CTD PMID:28329830 NCBI chr10:110,445,765...110,463,735
Ensembl chr10:110,445,797...110,463,727
JBrowse link
G Ncs1 neuronal calcium sensor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NCS1 mRNA CTD PMID:28329830 NCBI chr 3:10,556,250...10,602,672
Ensembl chr 3:10,553,589...10,602,672
JBrowse link
G Nde1 nudE neurodevelopment protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NDE1 mRNA CTD PMID:28329830 NCBI chr10:860,513...904,624
Ensembl chr10:860,521...896,938
JBrowse link
G Ndel1 nudE neurodevelopment protein 1-like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NDEL1 mRNA CTD PMID:28329830 NCBI chr10:55,398,919...55,456,654
Ensembl chr10:55,411,901...55,444,861
JBrowse link
G Ndrg1 N-myc downstream regulated 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NDRG1 mRNA CTD PMID:28329830 NCBI chr 7:107,734,326...107,775,701
Ensembl chr 7:107,734,323...107,775,714
JBrowse link
G Nedd4l NEDD4 like E3 ubiquitin protein ligase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NEDD4L mRNA CTD PMID:28329830 NCBI chr18:60,392,376...60,719,720
Ensembl chr18:60,392,376...60,719,720
JBrowse link
G Neurl3 neuralized E3 ubiquitin protein ligase 3 increases expression
multiple interactions
ISO fluoranthene results in increased expression of NEURL3 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of NEURL3 mRNA
CTD PMID:28329830 NCBI chr 9:42,831,737...42,841,765
Ensembl chr 9:42,831,742...42,839,837
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFE2L2 mRNA CTD PMID:28329830 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFIL3 mRNA CTD PMID:28329830 NCBI chr17:12,261,102...12,276,316
Ensembl chr17:12,261,102...12,276,315
JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFKB2 mRNA
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein
CTD PMID:28329830, PMID:30980910 NCBI chr 1:266,050,634...266,059,277
Ensembl chr 1:266,053,002...266,059,256
JBrowse link
G Nfkbie NFKB inhibitor epsilon multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFKBIE mRNA CTD PMID:28329830 NCBI chr 9:17,828,405...17,835,240
Ensembl chr 9:17,828,408...17,835,240
JBrowse link
G Nfkbiz NFKB inhibitor zeta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFKBIZ mRNA CTD PMID:28329830 NCBI chr11:47,243,342...47,271,487
Ensembl chr11:47,243,342...47,271,487
JBrowse link
G Nfyb nuclear transcription factor Y subunit beta decreases expression ISO fluoranthene results in decreased expression of NFYB mRNA CTD PMID:28329830 NCBI chr 7:27,081,667...27,097,481
Ensembl chr 7:27,081,667...27,097,479
JBrowse link
G Nhs NHS actin remodeling regulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NHS mRNA CTD PMID:28329830 NCBI chr  X:34,312,102...34,675,912
Ensembl chr  X:34,623,405...34,673,742
JBrowse link
G Nkain1 Sodium/potassium transporting ATPase interacting 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NKAIN1 mRNA CTD PMID:28329830 NCBI chr 5:148,635,537...148,669,709
Ensembl chr 5:148,661,070...148,667,746
JBrowse link
G Nmd3 NMD3 ribosome export adaptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NMD3 mRNA CTD PMID:28329830 NCBI chr 2:166,402,838...166,428,331
Ensembl chr 2:166,402,838...166,428,331
JBrowse link
G Nol8 nucleolar protein 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NOL8 mRNA CTD PMID:28329830 NCBI chr17:14,565,794...14,589,154
Ensembl chr17:14,565,794...14,589,154
Ensembl chr17:14,565,794...14,589,154
JBrowse link
G Nop58 NOP58 ribonucleoprotein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NOP58 mRNA CTD PMID:28329830 NCBI chr 9:66,495,881...66,520,521
Ensembl chr 9:66,495,832...66,519,788
JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
increases expression
ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [fluoranthene results in increased expression of NOS3 mRNA]; 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]; nickel chloride inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]; Proadifen inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]
fluoranthene results in increased expression of NOS3 mRNA; fluoranthene results in increased expression of NOS3 protein
CTD PMID:15183461 NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
increases expression
EXP
ISO
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NQO1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of NQO1 mRNA
fluoranthene results in increased expression of NQO1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of NQO1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of NQO1 mRNA]
CTD PMID:18711122, PMID:28329830 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Nqo2 N-ribosyldihydronicotinamide:quinone reductase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NQO2 mRNA CTD PMID:28329830 NCBI chr17:32,131,847...32,158,559
Ensembl chr17:32,132,347...32,158,538
JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR1D1 mRNA CTD PMID:28329830 NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815
JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR1D2 mRNA CTD PMID:28329830 NCBI chr15:8,730,871...8,757,165
Ensembl chr15:8,730,871...8,757,165
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 increases expression
multiple interactions
ISO fluoranthene results in increased expression of NR1H4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR1H4 mRNA
CTD PMID:28329830 NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO fluoranthene results in increased activity of NR1I3 protein CTD PMID:28927721 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases expression
multiple interactions
ISO fluoranthene results in increased expression of NR3C1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR3C1 mRNA
CTD PMID:28329830 NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA] CTD PMID:28329830 NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A2 mRNA CTD PMID:28329830 NCBI chr 3:43,111,258...43,128,391
Ensembl chr 3:43,111,240...43,119,159
JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A3 mRNA CTD PMID:28329830 NCBI chr 5:63,781,801...63,822,890
Ensembl chr 5:63,781,801...63,821,637
JBrowse link
G Nrg1 neuregulin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NRG1 mRNA CTD PMID:28329830 NCBI chr16:62,969,573...64,065,063
Ensembl chr16:63,837,216...64,057,434
JBrowse link
G Nsdhl NAD(P) dependent steroid dehydrogenase-like decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of NSDHL mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of NSDHL mRNA
CTD PMID:28329830 NCBI chr  X:152,933,118...152,964,399
Ensembl chr  X:152,933,069...152,964,390
JBrowse link
G Nt5dc3 5'-nucleotidase domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NT5DC3 mRNA CTD PMID:28329830 NCBI chr 7:27,309,963...27,365,687
Ensembl chr 7:27,309,966...27,363,394
JBrowse link
G Nudt16l1 nudix hydrolase 16 like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NUDT16L1 mRNA CTD PMID:28329830 NCBI chr10:10,829,866...10,831,782
Ensembl chr10:10,829,867...10,831,782
JBrowse link
G Nup58 nucleoporin 58 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUP58 mRNA CTD PMID:18711122 NCBI chr15:40,496,754...40,545,933
Ensembl chr15:40,513,342...40,545,824
JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUPR1 mRNA CTD PMID:18711122 NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
JBrowse link
G Oaz2 ornithine decarboxylase antizyme 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of OAZ2 mRNA CTD PMID:28329830 NCBI chr 8:71,216,011...71,229,788
Ensembl chr 8:71,216,178...71,228,713
JBrowse link
G Ogfrl1 opioid growth factor receptor-like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of OGFRL1 mRNA CTD PMID:28329830 NCBI chr 9:29,634,178...29,647,903
Ensembl chr 9:29,634,179...29,647,903
JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA] CTD PMID:28329830 NCBI chr 4:163,239,853...163,261,937
Ensembl chr 4:163,239,849...163,261,958
JBrowse link
G Olr143 olfactory receptor 143 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OLFR641 mRNA CTD PMID:28329830 NCBI chr 1:169,240,508...169,241,446
Ensembl chr 1:169,240,508...169,241,446
JBrowse link
G Oma1 OMA1 zinc metallopeptidase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of OMA1 mRNA CTD PMID:28329830 NCBI chr 5:122,847,624...122,900,475
Ensembl chr 5:122,847,645...122,900,475
JBrowse link
G Ormdl1 ORMDL sphingolipid biosynthesis regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ORMDL1 mRNA CTD PMID:28329830 NCBI chr 9:53,110,628...53,120,454
Ensembl chr 9:53,111,371...53,118,613
JBrowse link
G Ormdl2 ORMDL sphingolipid biosynthesis regulator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ORMDL2 mRNA CTD PMID:28329830 NCBI chr 7:3,242,991...3,246,085
Ensembl chr 7:3,242,991...3,246,071
JBrowse link
G Osbpl2 oxysterol binding protein-like 2 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSBPL2 mRNA
fluoranthene results in increased expression of OSBPL2 mRNA
CTD PMID:28329830 NCBI chr 3:175,493,650...175,538,965
Ensembl chr 3:175,493,698...175,538,963
JBrowse link
G Oser1 oxidative stress responsive serine-rich 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSER1 mRNA CTD PMID:28329830 NCBI chr 3:159,784,131...159,802,923
Ensembl chr 3:159,784,128...159,802,952
JBrowse link
G Osgin1 oxidative stress induced growth inhibitor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSGIN1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of OSGIN1 mRNA] CTD PMID:28329830 NCBI chr19:52,056,808...52,085,491
Ensembl chr19:52,077,109...52,085,496
JBrowse link
G Osmr oncostatin M receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSMR mRNA CTD PMID:28329830 NCBI chr 2:56,107,491...56,163,522
Ensembl chr 2:56,110,777...56,151,531
JBrowse link
G P4ha2 prolyl 4-hydroxylase subunit alpha 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of P4HA2 mRNA CTD PMID:28329830 NCBI chr10:39,435,227...39,464,134
Ensembl chr10:39,435,227...39,464,188
JBrowse link
G Paqr3 progestin and adipoQ receptor family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PAQR3 mRNA CTD PMID:28329830 NCBI chr14:14,107,513...14,129,780
Ensembl chr14:14,107,580...14,124,828
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO fluoranthene results in increased cleavage of PARP1 protein CTD PMID:21132278 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Pars2 prolyl-tRNA synthetase 2, mitochondrial multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PARS2 mRNA CTD PMID:28329830 NCBI chr 5:126,254,090...126,259,204
Ensembl chr 5:126,254,142...126,259,200
JBrowse link
G Pawr pro-apoptotic WT1 regulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PAWR mRNA CTD PMID:28329830 NCBI chr 7:51,273,764...51,353,700
Ensembl chr 7:51,273,771...51,353,068
JBrowse link
G Pcbd2 pterin-4 alpha-carbinolamine dehydratase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PCBD2 mRNA CTD PMID:28329830 NCBI chr17:8,929,675...8,980,712
Ensembl chr17:8,929,810...8,980,571
JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PDK1 mRNA CTD PMID:28329830 NCBI chr 3:58,530,870...58,561,494
Ensembl chr 3:58,530,870...58,558,027
JBrowse link
G Per1 period circadian regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PER1 mRNA CTD PMID:28329830 NCBI chr10:55,681,761...55,696,557
Ensembl chr10:55,687,050...55,695,994
JBrowse link
G Per2 period circadian regulator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PER2 mRNA CTD PMID:28329830 NCBI chr 9:98,555,154...98,597,362
Ensembl chr 9:98,555,169...98,597,359
JBrowse link
G Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of PFKFB1 mRNA CTD PMID:18711122 NCBI chr  X:23,092,143...23,145,923
Ensembl chr  X:23,092,159...23,144,324
JBrowse link
G Pfkl phosphofructokinase, liver type multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PFKL mRNA CTD PMID:28329830 NCBI chr20:11,393,860...11,415,889
Ensembl chr20:11,393,877...11,415,882
JBrowse link
G Pgam1 phosphoglycerate mutase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGAM1 mRNA CTD PMID:28329830 NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
JBrowse link
G Pgm2 phosphoglucomutase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGM2 mRNA CTD PMID:28329830 NCBI chr14:45,829,440...45,863,883
Ensembl chr14:45,829,446...45,863,877
JBrowse link
G Pgp phosphoglycolate phosphatase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGP mRNA CTD PMID:28329830 NCBI chr10:13,836,105...13,838,731
Ensembl chr10:13,836,128...13,838,765
JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PHLDA1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PHLDA1 mRNA]
fluoranthene results in increased expression of PHLDA1 mRNA
CTD PMID:28329830 NCBI chr 7:54,247,460...54,249,664
Ensembl chr 7:54,247,460...54,249,664
JBrowse link
G Pi4k2b phosphatidylinositol 4-kinase type 2 beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PI4K2B mRNA CTD PMID:28329830 NCBI chr14:60,567,968...60,594,821
Ensembl chr14:60,567,967...60,594,844
JBrowse link
G Pim3 Pim-3 proto-oncogene, serine/threonine kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PIM3 mRNA CTD PMID:28329830 NCBI chr 7:129,856,467...129,863,441
Ensembl chr 7:129,860,114...129,863,441
JBrowse link
G Pip4k2b phosphatidylinositol-5-phosphate 4-kinase type 2 beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PIP4K2B mRNA CTD PMID:28329830 NCBI chr10:85,655,223...85,684,138
Ensembl chr10:85,658,324...85,684,138
JBrowse link
G Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 1 increases expression
multiple interactions
ISO fluoranthene results in increased expression of PITPNC1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of PITPNC1 mRNA
CTD PMID:28329830 NCBI chr10:95,429,879...95,697,734 JBrowse link
G Pla2g4a phospholipase A2 group IVA multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLA2G4A mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of PLA2G4A protein CTD PMID:28329830, PMID:30690640 NCBI chr13:67,062,252...67,206,688
Ensembl chr13:66,988,937...67,206,693
JBrowse link
G Plaur plasminogen activator, urokinase receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLAUR mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PLAUR mRNA] CTD PMID:28329830 NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
JBrowse link
G Plcd3 phospholipase C, delta 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLCD3 mRNA CTD PMID:28329830 NCBI chr10:91,164,778...91,186,067
Ensembl chr10:91,164,812...91,186,054
JBrowse link
G Plcl2 phospholipase C-like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLCL2 mRNA CTD PMID:28329830 NCBI chr 9:1,782,536...1,984,654
Ensembl chr 9:1,782,536...1,984,654
JBrowse link
G Plekha2 pleckstrin homology domain containing A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PLEKHA2 mRNA CTD PMID:28329830 NCBI chr16:71,725,649...71,784,432
Ensembl chr16:71,738,718...71,787,787
JBrowse link
G Plekhf1 pleckstrin homology and FYVE domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLEKHF1 mRNA CTD PMID:28329830 NCBI chr 1:94,609,041...94,616,565
Ensembl chr 1:94,609,377...94,610,854
JBrowse link
G Plk2 polo-like kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLK2 mRNA CTD PMID:28329830 NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
JBrowse link
G Plk3 polo-like kinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLK3 mRNA CTD PMID:28329830 NCBI chr 5:135,997,725...136,002,900
Ensembl chr 5:135,997,725...136,002,900
JBrowse link
G Plpp1 phospholipid phosphatase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PPAP2A mRNA CTD PMID:28329830 NCBI chr 2:44,664,076...44,726,820
Ensembl chr 2:44,664,124...44,726,689
JBrowse link
G Pml PML nuclear body scaffold multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PML mRNA CTD PMID:28329830 NCBI chr 8:63,002,515...63,034,310
Ensembl chr 8:63,004,870...63,034,226
JBrowse link
G Pnrc2 proline-rich nuclear receptor coactivator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PNRC2 mRNA CTD PMID:28329830 NCBI chr 5:154,220,552...154,223,536
Ensembl chr 5:154,218,852...154,223,536
JBrowse link
G Polr2d RNA polymerase II subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POLR2D mRNA CTD PMID:28329830 NCBI chr18:24,570,762...24,577,894
Ensembl chr18:24,570,762...24,577,894
JBrowse link
G Polr3d RNA polymerase III subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of POLR3D mRNA CTD PMID:28329830 NCBI chr15:52,129,471...52,134,140
Ensembl chr15:52,129,471...52,134,140
JBrowse link
G Polr3g RNA polymerase III subunit G multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POLR3G mRNA CTD PMID:28329830 NCBI chr 2:9,537,642...9,578,551
Ensembl chr 2:9,537,642...9,578,310
JBrowse link
G Pomgnt2 protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POMGNT2 mRNA CTD PMID:28329830 NCBI chr 8:130,615,482...130,631,144
Ensembl chr 8:130,615,711...130,617,833
JBrowse link
G Pomk protein-O-mannose kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POMK mRNA CTD PMID:28329830 NCBI chr16:70,854,825...70,869,653
Ensembl chr16:70,859,280...70,869,634
JBrowse link
G Ppan peter pan homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPAN mRNA CTD PMID:28329830 NCBI chr 8:21,905,865...21,909,845
Ensembl chr 8:21,905,865...21,909,842
JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPARD mRNA CTD PMID:28329830 NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPP1R15A mRNA CTD PMID:28329830 NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
JBrowse link
G Ppp1r3b protein phosphatase 1, regulatory subunit 3B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PPP1R3B mRNA CTD PMID:28329830 NCBI chr16:60,415,192...60,427,498
Ensembl chr16:60,415,229...60,427,474
JBrowse link
G Pprc1 PPARG related coactivator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPRC1 mRNA CTD PMID:28329830 NCBI chr 1:265,809,892...265,826,319
Ensembl chr 1:265,809,754...265,826,306
JBrowse link
G Prelid1 PRELI domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRELID1 mRNA CTD PMID:28329830 NCBI chr17:9,834,245...9,837,285
Ensembl chr17:9,834,242...9,837,303
JBrowse link
G Prelp proline and arginine rich end leucine rich repeat protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRELP mRNA CTD PMID:28329830 NCBI chr13:50,749,526...50,773,934
Ensembl chr13:50,749,514...50,761,355
JBrowse link
G Prkaca protein kinase cAMP-activated catalytic subunit alpha multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRKACA mRNA CTD PMID:28329830 NCBI chr19:25,095,089...25,118,869
Ensembl chr19:25,095,089...25,118,860
JBrowse link
G Ptgr1 prostaglandin reductase 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of PTGR1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of PTGR1 mRNA CTD PMID:18711122 NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression
multiple interactions
ISO fluoranthene results in increased expression of PTGS2 mRNA
[1-methylanthracene co-treated with fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA]; [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTGS2 mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTGS2 protein; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PTGS2 mRNA]
CTD PMID:28329830, PMID:29170806, PMID:30690640 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Ptpn2 protein tyrosine phosphatase, non-receptor type 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPN2 mRNA CTD PMID:28329830 NCBI chr18:63,415,298...63,489,240
Ensembl chr18:63,415,306...63,488,027
JBrowse link
G Ptpn22 protein tyrosine phosphatase, non-receptor type 22 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPN22 mRNA CTD PMID:28329830 NCBI chr 2:206,342,066...206,390,348
Ensembl chr 2:206,342,066...206,390,348
JBrowse link
G Ptpre protein tyrosine phosphatase, receptor type, E multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPRE mRNA CTD PMID:28329830 NCBI chr 1:207,820,719...207,987,123
Ensembl chr 1:207,887,209...207,987,136
JBrowse link
G Ptx3 pentraxin 3 multiple interactions
increases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTX3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PTX3 mRNA]
fluoranthene results in increased expression of PTX3 mRNA
CTD PMID:28329830 NCBI chr 2:158,097,843...158,103,653
Ensembl chr 2:158,097,843...158,103,653
JBrowse link
G Pvr PVR cell adhesion molecule multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PVR mRNA CTD PMID:28329830 NCBI chr 1:80,820,306...80,835,712
Ensembl chr 1:80,820,050...80,835,701
JBrowse link
G Pxdc1 PX domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PXDC1 mRNA CTD PMID:28329830 NCBI chr17:30,965,420...30,994,411
Ensembl chr17:30,965,942...30,994,410
JBrowse link
G Pxdn peroxidasin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PXDN mRNA CTD PMID:28329830 NCBI chr 6:48,866,496...48,982,368
Ensembl chr 6:48,866,601...48,980,340
JBrowse link
G Qpctl glutaminyl-peptide cyclotransferase-like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of QPCTL mRNA CTD PMID:28329830 NCBI chr 1:80,046,975...80,057,022
Ensembl chr 1:80,047,504...80,056,574
JBrowse link
G Qtrt2 queuine tRNA-ribosyltransferase accessory subunit 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of QTRT2 mRNA CTD PMID:28329830 NCBI chr11:61,748,822...61,779,631
Ensembl chr11:61,748,878...61,779,631
JBrowse link
G Rab1b RAB1B, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RAB1B mRNA CTD PMID:28329830 NCBI chr 1:220,483,529...220,491,469
Ensembl chr 1:220,480,834...220,491,469
JBrowse link
G Rab20 RAB20, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RAB20 mRNA CTD PMID:28329830 NCBI chr16:83,358,116...83,382,326
Ensembl chr16:83,358,116...83,382,326
JBrowse link
G Rab29 RAB29, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RAB29 mRNA CTD PMID:28329830 NCBI chr13:48,644,575...48,650,229
Ensembl chr13:48,644,604...48,650,220
JBrowse link
G Rab3d RAB3D, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RAB3D mRNA CTD PMID:28329830 NCBI chr 8:22,920,238...22,929,368
Ensembl chr 8:22,918,699...22,929,294
JBrowse link
G Rabggtb Rab geranylgeranyltransferase subunit beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RABGGTB mRNA CTD PMID:28329830 NCBI chr 2:260,110,309...260,115,574
Ensembl chr 2:260,110,309...260,115,577
JBrowse link
G Ranbp9 RAN binding protein 9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RANBP9 mRNA CTD PMID:28329830 NCBI chr17:24,020,874...24,103,771
Ensembl chr17:24,021,736...24,103,515
JBrowse link
G Rapgef2 Rap guanine nucleotide exchange factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RAPGEF2 mRNA CTD PMID:28329830 NCBI chr 2:177,836,191...178,057,378
Ensembl chr 2:177,836,202...178,057,157
JBrowse link
G Rasgef1b RasGEF domain family, member 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASGEF1B mRNA CTD PMID:28329830 NCBI chr14:11,499,692...12,028,513
Ensembl chr14:11,988,671...12,027,381
JBrowse link
G Rassf1 Ras association domain family member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASSF1 mRNA CTD PMID:28329830 NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
JBrowse link
G Rassf3 Ras association domain family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RASSF3 mRNA CTD PMID:28329830 NCBI chr 7:63,513,825...63,578,499
Ensembl chr 7:63,513,910...63,578,490
JBrowse link
G Rassf8 Ras association domain family member 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASSF8 mRNA CTD PMID:28329830 NCBI chr 4:180,059,020...180,135,924
Ensembl chr 4:180,062,799...180,135,966
JBrowse link
G Rbm33 RNA binding motif protein 33 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RBM33 mRNA CTD PMID:28329830 NCBI chr 4:592,616...700,903
Ensembl chr 4:594,882...695,383
JBrowse link
G Rdh11 retinol dehydrogenase 11 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of RDH11 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of RDH11 mRNA
CTD PMID:28329830 NCBI chr 6:102,356,498...102,372,618
Ensembl chr 6:102,356,492...102,372,611
JBrowse link
G Reck reversion-inducing-cysteine-rich protein with kazal motifs multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RECK mRNA CTD PMID:28329830 NCBI chr 5:59,348,568...59,415,169
Ensembl chr 5:59,348,639...59,415,135
JBrowse link
G Reep6 receptor accessory protein 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of REEP6 mRNA CTD PMID:28329830 NCBI chr 7:12,240,059...12,246,814
Ensembl chr 7:12,240,060...12,246,729
JBrowse link
G Relb RELB proto-oncogene, NF-kB subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RELB mRNA CTD PMID:28329830 NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
JBrowse link
G Rflnb refilin B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RFLNB mRNA CTD PMID:28329830 NCBI chr10:64,196,103...64,202,380
Ensembl chr10:64,196,127...64,202,380
JBrowse link
G RGD1563888 similar to DNA segment, Chr 16, ERATO Doi 472, expressed multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of D16ERTD472E mRNA CTD PMID:28329830 NCBI chr11:17,073,296...17,120,235
Ensembl chr11:17,076,980...17,130,120
JBrowse link
G Rhbdd2 rhomboid domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RHBDD2 mRNA CTD PMID:28329830 NCBI chr12:24,091,132...24,102,081
Ensembl chr12:24,092,004...24,102,084
JBrowse link
G Rhbdf2 rhomboid 5 homolog 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RHBDF2 mRNA CTD PMID:28329830 NCBI chr10:105,573,759...105,600,885
Ensembl chr10:105,573,752...105,600,913
JBrowse link
G Rhob ras homolog family member B decreases expression ISO fluoranthene results in decreased expression of RHOB mRNA CTD PMID:28329830 NCBI chr 6:33,689,127...33,691,301
Ensembl chr 6:33,689,127...33,691,301
JBrowse link
G Rhpn2 rhophilin, Rho GTPase binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RHPN2 mRNA CTD PMID:28329830 NCBI chr 1:91,596,344...91,657,395
Ensembl chr 1:91,596,397...91,657,395
JBrowse link
G Ripk2 receptor-interacting serine-threonine kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RIPK2 mRNA CTD PMID:28329830 NCBI chr 5:29,838,713...29,870,390
Ensembl chr 5:29,838,747...29,870,735
JBrowse link
G Rnd1 Rho family GTPase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RND1 mRNA CTD PMID:28329830 NCBI chr 7:140,349,138...140,356,209
Ensembl chr 7:140,349,138...140,356,209
JBrowse link
G Rnd3 Rho family GTPase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RND3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of RND3 mRNA] CTD PMID:28329830 NCBI chr 3:36,643,374...36,660,727
Ensembl chr 3:36,642,587...36,660,758
JBrowse link
G Rnf125 ring finger protein 125 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF125 mRNA CTD PMID:28329830 NCBI chr18:15,193,226...15,225,454
Ensembl chr18:15,192,962...15,225,427
JBrowse link
G Rnf19b ring finger protein 19B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF19B mRNA CTD PMID:28329830 NCBI chr 5:147,246,032...147,270,892
Ensembl chr 5:147,246,037...147,270,957
JBrowse link
G Rnf217 ring finger protein 217 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF217 mRNA CTD PMID:28329830 NCBI chr 1:28,301,960...28,391,582
Ensembl chr 1:28,301,922...28,390,837
JBrowse link
G Rora RAR-related orphan receptor A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RORA mRNA CTD PMID:28329830 NCBI chr 8:75,515,886...75,616,477
Ensembl chr 8:75,516,904...75,607,212
JBrowse link
G Rpp38 ribonuclease P/MRP subunit p38 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RPP38 mRNA CTD PMID:28329830 NCBI chr17:78,915,450...78,919,144
Ensembl chr17:78,915,604...78,919,143
JBrowse link
G Rrad RRAD, Ras related glycolysis inhibitor and calcium channel regulator multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of RRAD mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of RRAD mRNA CTD PMID:18711122 NCBI chr19:561,696...564,929
Ensembl chr19:561,727...564,930
JBrowse link
G Rusc2 RUN and SH3 domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RUSC2 mRNA CTD PMID:28329830 NCBI chr 5:58,860,444...58,883,152
Ensembl chr 5:58,855,773...58,882,096
JBrowse link
G S100a16 S100 calcium binding protein A16 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of S100A16 mRNA CTD PMID:28329830 NCBI chr 2:189,923,140...189,928,850
Ensembl chr 2:189,922,996...189,928,848
JBrowse link
G S100a4 S100 calcium-binding protein A4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of S100A4 mRNA CTD PMID:28329830 NCBI chr 2:189,997,278...189,999,587
Ensembl chr 2:189,997,129...189,999,604
JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SAT1 mRNA CTD PMID:17690111 NCBI chr  X:43,626,480...43,629,767
Ensembl chr  X:43,625,169...43,629,765
JBrowse link
G Sbno2 strawberry notch homolog 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SBNO2 mRNA CTD PMID:28329830 NCBI chr 7:12,471,805...12,515,700
Ensembl chr 7:12,471,824...12,518,654
JBrowse link
G Sc5d sterol-C5-desaturase decreases expression ISO fluoranthene results in decreased expression of SC5D mRNA CTD PMID:28329830 NCBI chr 8:46,525,406...46,537,014
Ensembl chr 8:46,525,400...46,537,050
JBrowse link
G Scamp5 secretory carrier membrane protein 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SCAMP5 mRNA CTD PMID:28329830 NCBI chr 8:62,221,820...62,266,269
Ensembl chr 8:62,220,892...62,248,017
JBrowse link
G Scx scleraxis bHLH transcription factor multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SCX mRNA
fluoranthene results in decreased expression of SCX mRNA
CTD PMID:28329830 NCBI chr 7:117,519,075...117,521,093
Ensembl chr 7:117,519,075...117,521,093
JBrowse link
G Sdad1 SDA1 domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SDAD1 mRNA CTD PMID:28329830 NCBI chr14:17,247,381...17,274,228
Ensembl chr14:17,247,362...17,274,623
JBrowse link
G Sde2 SDE2 telomere maintenance homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SDE2 mRNA CTD PMID:28329830 NCBI chr13:99,136,921...99,153,187
Ensembl chr13:99,136,871...99,153,181
JBrowse link
G Sec16a SEC16 homolog A, endoplasmic reticulum export factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SEC16A mRNA CTD PMID:28329830 NCBI chr 3:3,856,218...3,890,785
Ensembl chr 3:3,856,218...3,890,758
JBrowse link
G Sec23a Sec23 homolog A, COPII coat complex component multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SEC23A mRNA CTD PMID:28329830 NCBI chr 6:80,059,742...80,107,340
Ensembl chr 6:80,060,916...80,107,236
JBrowse link
G Sec24a SEC24 homolog A, COPII coat complex component multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SEC24A mRNA CTD PMID:28329830 NCBI chr10:37,138,539...37,215,899
Ensembl chr10:37,139,806...37,215,899
JBrowse link
G Sema7a semaphorin 7A (John Milton Hagen blood group) decreases expression ISO fluoranthene results in decreased expression of SEMA7A mRNA CTD PMID:28329830 NCBI chr 8:62,723,788...62,746,530
Ensembl chr 8:62,723,788...62,745,868
JBrowse link
G Senp8 SUMO peptidase family member, NEDD8 specific multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SENP8 mRNA CTD PMID:28329830 NCBI chr 8:64,558,994...64,572,850
Ensembl chr 8:64,559,015...64,572,850
JBrowse link
G Sephs2 selenophosphate synthetase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SEPHS2 mRNA CTD PMID:28329830 NCBI chr 1:198,719,158...198,721,476
Ensembl chr 1:198,719,162...198,721,476
JBrowse link
G Serpina3m serpin family A member 3M multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SERPINA3 mRNA CTD PMID:17690111 NCBI chr 6:127,808,785...127,816,067
Ensembl chr 6:127,808,785...127,816,055
JBrowse link
G Serpinb2 serpin family B member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SERPINB2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SERPINB2 mRNA] CTD PMID:28329830 NCBI chr13:27,449,907...27,463,015
Ensembl chr13:27,449,934...27,463,010
JBrowse link
G Serpind1 serpin family D member 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SERPIND1 mRNA CTD PMID:18711122 NCBI chr11:87,913,814...87,924,880
Ensembl chr11:87,913,806...87,924,816
JBrowse link
G Sesn1 sestrin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SESN1 mRNA CTD PMID:28329830 NCBI chr20:46,667,116...46,758,306
Ensembl chr20:46,667,121...46,758,305
JBrowse link
G Sesn2 sestrin 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SESN2 mRNA CTD PMID:28329830 NCBI chr 5:150,684,891...150,703,846
Ensembl chr 5:150,684,133...150,704,117
JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SGK1 mRNA CTD PMID:28329830 NCBI chr 1:24,185,451...24,302,309
Ensembl chr 1:24,185,435...24,302,298
JBrowse link
G Sh3bgrl3 SH3 domain binding glutamate-rich protein like 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SH3BGRL3 mRNA CTD PMID:28329830 NCBI chr 5:152,357,270...152,358,643
Ensembl chr 5:152,357,270...152,358,643
JBrowse link
G Sigmar1 sigma non-opioid intracellular receptor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SIGMAR1 mRNA CTD PMID:28329830 NCBI chr 5:58,121,824...58,124,687
Ensembl chr 5:58,121,786...58,124,681
JBrowse link
G Skil SKI-like proto-oncogene multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SKIL mRNA CTD PMID:28329830 NCBI chr 2:115,862,932...115,891,304
Ensembl chr 2:115,866,701...115,891,097
JBrowse link
G Sla src-like adaptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLA mRNA CTD PMID:28329830 NCBI chr 7:107,585,055...107,604,950
Ensembl chr 7:107,584,118...107,634,335
JBrowse link
G Slc12a2 solute carrier family 12 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC12A2 mRNA CTD PMID:28329830 NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
JBrowse link
G Slc16a1 solute carrier family 16 member 1 multiple interactions EXP [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA CTD PMID:18711122 NCBI chr 2:207,108,552...207,129,352
Ensembl chr 2:207,108,552...207,128,554
JBrowse link
G Slc16a2 solute carrier family 16 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC16A2 mRNA CTD PMID:28329830 NCBI chr  X:74,578,600...74,706,068
Ensembl chr  X:74,577,131...74,706,214
JBrowse link
G Slc18b1 solute carrier family 18 member B1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC18B1 mRNA CTD PMID:28329830 NCBI chr 1:22,705,980...22,748,571
Ensembl chr 1:22,705,916...22,748,422
JBrowse link
G Slc1a4 solute carrier family 1 member 4 increases expression
multiple interactions
ISO fluoranthene results in increased expression of SLC1A4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC1A4 mRNA
CTD PMID:28329830 NCBI chr14:104,582,884...104,612,417
Ensembl chr14:104,581,190...104,612,597
JBrowse link
G Slc20a1 solute carrier family 20 member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC20A1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC20A1 mRNA] CTD PMID:28329830 NCBI chr 3:121,725,204...121,739,160
Ensembl chr 3:121,725,859...121,739,173
JBrowse link
G Slc22a23 solute carrier family 22, member 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC22A23 mRNA CTD PMID:28329830 NCBI chr17:31,236,015...31,403,685
Ensembl chr17:31,236,015...31,403,685
JBrowse link
G Slc25a13 solute carrier family 25 member 13 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC25A13 mRNA CTD PMID:28329830 NCBI chr 4:31,134,165...31,757,006
Ensembl chr 4:31,608,269...31,730,386
JBrowse link
G Slc25a23 solute carrier family 25 member 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC25A23 mRNA CTD PMID:28329830 NCBI chr 9:9,987,988...10,003,599
Ensembl chr 9:9,988,055...10,001,962
JBrowse link
G Slc25a25 solute carrier family 25 member 25 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A25 mRNA CTD PMID:28329830 NCBI chr 3:11,442,396...11,476,186
Ensembl chr 3:11,442,397...11,452,529
JBrowse link
G Slc25a30 solute carrier family 25, member 30 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A30 mRNA CTD PMID:28329830 NCBI chr15:57,811,612...57,834,173
Ensembl chr15:57,813,356...57,834,173
JBrowse link
G Slc25a37 solute carrier family 25 member 37 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA CTD PMID:28329830 NCBI chr15:51,125,764...51,168,384
Ensembl chr15:51,128,268...51,168,384
JBrowse link
G Slc29a3 solute carrier family 29 member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC29A3 mRNA CTD PMID:28329830 NCBI chr20:30,289,527...30,327,343
Ensembl chr20:30,287,424...30,327,361
JBrowse link
G Slc30a4 solute carrier family 30 member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC30A4 mRNA CTD PMID:28329830 NCBI chr 3:114,805,919...114,828,154
Ensembl chr 3:114,805,922...114,828,154
JBrowse link
G Slc31a2 solute carrier family 31 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC31A2 mRNA CTD PMID:28329830 NCBI chr 5:78,120,606...78,131,111
Ensembl chr 5:78,120,607...78,131,114
JBrowse link
G Slc35d2 solute carrier family 35 member D2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC35D2 mRNA CTD PMID:28329830 NCBI chr17:1,618,641...1,649,734
Ensembl chr17:1,618,189...1,648,973
JBrowse link
G Slc35g1 solute carrier family 35, member G1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC35G1 mRNA CTD PMID:28329830 NCBI chr 1:257,076,221...257,082,655
Ensembl chr 1:257,076,221...257,082,655
JBrowse link
G Slc38a2 solute carrier family 38, member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC38A2 mRNA CTD PMID:28329830 NCBI chr 7:138,088,654...138,100,869
Ensembl chr 7:138,088,649...138,100,841
JBrowse link
G Slc38a6 solute carrier family 38, member 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC38A6 mRNA CTD PMID:28329830 NCBI chr 6:96,171,756...96,241,512
Ensembl chr 6:96,171,756...96,241,096
JBrowse link
G Slc3a2 solute carrier family 3 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC3A2 mRNA CTD PMID:28329830 NCBI chr 1:224,906,566...224,921,029
Ensembl chr 1:224,906,554...224,921,092
JBrowse link
G Slc7a1 solute carrier family 7 member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA] CTD PMID:28329830 NCBI chr12:8,032,775...8,108,972
Ensembl chr12:8,032,809...8,108,972
JBrowse link
G Slc7a11 solute carrier family 7 member 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA] CTD PMID:28329830 NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
JBrowse link
G Slc9a3r1 SLC9A3 regulator 1 decreases expression ISO fluoranthene results in decreased expression of SLC9A3R1 mRNA CTD PMID:28329830 NCBI chr10:103,713,045...103,730,145
Ensembl chr10:103,713,045...103,730,145
JBrowse link
G Smad3 SMAD family member 3 multiple interactions EXP
ISO
[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SMAD3 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of SMAD3 mRNA
CTD PMID:18711122, PMID:28329830 NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
JBrowse link
G Smad6 SMAD family member 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMAD6 mRNA CTD PMID:28329830 NCBI chr 8:68,897,746...68,967,221
Ensembl chr 8:68,898,296...68,966,108
JBrowse link
G Smim11a small integral membrane protein 11A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMIM11 mRNA CTD PMID:28329830 NCBI chr11:32,450,508...32,460,244
Ensembl chr11:32,450,587...32,460,238
JBrowse link
G Smim3 small integral membrane protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SMIM3 mRNA CTD PMID:28329830 NCBI chr18:55,744,809...55,797,186
Ensembl chr18:55,744,810...55,771,730
JBrowse link
G Smtnl2 smoothelin-like 2 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of SMTNL2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMTNL2 mRNA
CTD PMID:28329830 NCBI chr10:58,951,845...58,973,020
Ensembl chr10:58,951,842...58,973,020
JBrowse link
G Snai2 snail family transcriptional repressor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNAI2 mRNA CTD PMID:28329830 NCBI chr11:90,404,421...90,406,730
Ensembl chr11:90,403,333...90,406,797
JBrowse link
G Snapin SNAP-associated protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SNAPIN mRNA CTD PMID:28329830 NCBI chr 2:189,878,159...189,880,743
Ensembl chr 2:189,878,168...189,880,743
JBrowse link
G Snx7 sorting nexin 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SNX7 mRNA CTD PMID:28329830 NCBI chr 2:221,015,302...221,099,810
Ensembl chr 2:221,015,310...221,099,738
JBrowse link
G Socs3 suppressor of cytokine signaling 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SOCS3 mRNA CTD PMID:28329830 NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
JBrowse link
G Soga3 SOGA family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SOGA3 mRNA CTD PMID:28329830 NCBI chr 1:31,066,241...31,124,885
Ensembl chr 1:31,066,798...31,122,093
JBrowse link
G Sorbs3 sorbin and SH3 domain containing 3 multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SORBS3 mRNA
fluoranthene results in decreased expression of SORBS3 mRNA
CTD PMID:28329830 NCBI chr15:51,859,004...51,895,707
Ensembl chr15:51,859,462...51,890,832
JBrowse link
G Sox4 SRY-box transcription factor 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SOX4 mRNA CTD PMID:28329830 NCBI chr17:37,615,022...37,619,728 JBrowse link
G Sp3 Sp3 transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SP3 mRNA CTD PMID:28329830 NCBI chr 3:59,644,579...59,689,011
Ensembl chr 3:59,646,015...59,688,692
JBrowse link
G Spata5 spermatogenesis associated 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPATA5 mRNA CTD PMID:28329830 NCBI chr 2:124,149,872...124,341,138
Ensembl chr 2:124,149,872...124,341,131
JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SPP1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of SPP1 mRNA
CTD PMID:17690111, PMID:28329830 NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
JBrowse link
G Spred1 sprouty-related, EVH1 domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRED1 mRNA CTD PMID:28329830 NCBI chr 3:108,795,337...108,861,650
Ensembl chr 3:108,795,235...108,857,556
JBrowse link
G Spry2 sprouty RTK signaling antagonist 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY2 mRNA CTD PMID:28329830 NCBI chr15:90,172,769...90,177,823
Ensembl chr15:90,172,975...90,175,802
JBrowse link
G Spry4 sprouty RTK signaling antagonist 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY4 mRNA CTD PMID:28329830 NCBI chr18:32,593,370...32,609,890
Ensembl chr18:32,594,958...32,609,864
JBrowse link
G Sptbn2 spectrin, beta, non-erythrocytic 2 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SPTBN2 mRNA CTD PMID:18711122 NCBI chr 1:219,964,429...220,006,811
Ensembl chr 1:219,964,429...220,005,068
JBrowse link
G Spty2d1 SPT2 chromatin protein domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPTY2D1 mRNA CTD PMID:28329830 NCBI chr 1:103,115,280...103,129,438
Ensembl chr 1:103,115,216...103,128,743
JBrowse link
G Sqle squalene epoxidase decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of SQLE mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SQLE mRNA
CTD PMID:28329830 NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
JBrowse link
G Srgap3 SLIT-ROBO Rho GTPase activating protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SRGAP3 mRNA CTD PMID:28329830 NCBI chr 4:144,638,782...144,869,961
Ensembl chr 4:144,638,335...144,869,919
JBrowse link
G Sri sorcin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SRI mRNA CTD PMID:28329830 NCBI chr 4:23,004,657...23,029,233
Ensembl chr 4:23,006,243...23,018,983
JBrowse link
G Stam signal transducing adaptor molecule multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STAM mRNA CTD PMID:28329830 NCBI chr17:81,209,795...81,256,111
Ensembl chr17:81,209,867...81,255,808
JBrowse link
G Stambpl1 STAM binding protein-like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STAMBPL1 mRNA CTD PMID:28329830 NCBI chr 1:252,490,125...252,536,113
Ensembl chr 1:252,497,452...252,536,104
JBrowse link
G Stard10 StAR-related lipid transfer domain containing 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of STARD10 mRNA CTD PMID:28329830 NCBI chr 1:166,428,780...166,458,413
Ensembl chr 1:166,428,761...166,457,509
JBrowse link
G Stard4 StAR-related lipid transfer domain containing 4 decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of STARD4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of STARD4 mRNA
CTD PMID:28329830 NCBI chr18:25,982,210...25,997,555
Ensembl chr18:25,984,638...25,997,555
JBrowse link
G Stc1 stanniocalcin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of STC1 mRNA CTD PMID:28329830 NCBI chr15:50,891,137...50,901,791
Ensembl chr15:50,891,127...50,903,162
JBrowse link
G Stk40 serine/threonine kinase 40 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STK40 mRNA CTD PMID:28329830 NCBI chr 5:144,112,612...144,150,653
Ensembl chr 5:144,114,012...144,150,647
JBrowse link
G Stx3 syntaxin 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STX3 mRNA CTD PMID:28329830 NCBI chr 1:228,137,781...228,195,004
Ensembl chr 1:228,149,867...228,194,977
JBrowse link
G Suco SUN domain containing ossification factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SUCO mRNA CTD PMID:28329830 NCBI chr13:79,736,485...79,801,133
Ensembl chr13:79,736,482...79,801,561
JBrowse link
G Suox sulfite oxidase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SUOX mRNA CTD PMID:28329830 NCBI chr 7:3,098,228...3,102,179
Ensembl chr 7:3,098,245...3,102,142
JBrowse link
G Syde1 synapse defective Rho GTPase homolog 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SYDE1 mRNA CTD PMID:28329830 NCBI chr 7:14,037,646...14,043,632
Ensembl chr 7:14,037,620...14,043,779
JBrowse link
G Synj2 synaptojanin 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SYNJ2 mRNA CTD PMID:28329830 NCBI chr 1:46,835,922...46,932,544
Ensembl chr 1:46,835,971...46,932,529
JBrowse link
G Taf1a TATA-box binding protein associated factor, RNA polymerase I subunit A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1A mRNA CTD PMID:28329830 NCBI chr13:101,770,278...101,807,975
Ensembl chr13:101,790,865...101,806,900
JBrowse link
G Taf1d TATA-box binding protein associated factor, RNA polymerase I subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1D mRNA CTD PMID:28329830 NCBI chr 8:13,861,242...13,871,508
Ensembl chr 8:13,861,459...13,871,354
JBrowse link
G Taf4b TATA-box binding protein associated factor 4b multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF4B mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF4B mRNA] CTD PMID:28329830 NCBI chr18:6,206,939...6,338,794
Ensembl chr18:6,207,280...6,318,219
JBrowse link
G Taf5 TATA-box binding protein associated factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF5 mRNA CTD PMID:28329830 NCBI chr 1:266,844,480...266,859,965
Ensembl chr 1:266,844,480...266,859,965
JBrowse link
G Tanc2 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TANC2 mRNA CTD PMID:28329830 NCBI chr10:93,811,350...94,132,418
Ensembl chr10:93,811,350...94,127,697
JBrowse link
G Tank TRAF family member-associated NFKB activator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TANK mRNA CTD PMID:28329830 NCBI chr 3:47,439,007...47,515,706
Ensembl chr 3:47,439,076...47,515,700
JBrowse link
G Tatdn2 TatD DNase domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TATDN2 mRNA CTD PMID:28329830 NCBI chr 4:145,653,299...145,669,343
Ensembl chr 4:145,653,602...145,669,343
JBrowse link
G Tbc1d15 TBC1 domain family, member 15 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D15 mRNA CTD PMID:28329830 NCBI chr 7:58,164,190...58,219,804
Ensembl chr 7:58,164,198...58,219,790
JBrowse link
G Tbc1d23 TBC1 domain family, member 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D23 mRNA CTD PMID:28329830 NCBI chr11:45,401,396...45,459,841
Ensembl chr11:45,401,403...45,459,821
JBrowse link
G Tbc1d31 TBC1 domain family, member 31 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D31 mRNA CTD PMID:28329830 NCBI chr 7:97,778,260...97,839,668
Ensembl chr 7:97,760,134...97,839,668
JBrowse link
G Tbccd1 TBCC domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TBCCD1 mRNA CTD PMID:28329830 NCBI chr11:81,757,963...81,794,367
Ensembl chr11:81,757,983...81,794,580
JBrowse link
G Tcp11l2 t-complex 11 like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TCP11L2 mRNA CTD PMID:28329830 NCBI chr 7:24,859,048...24,893,907
Ensembl chr 7:24,859,050...24,885,775
JBrowse link
G Tef TEF transcription factor, PAR bZIP family member multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TEF mRNA CTD PMID:28329830 NCBI chr 7:123,033,971...123,058,606
Ensembl chr 7:123,043,503...123,058,604
JBrowse link
G Tex261 testis expressed 261 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TEX261 mRNA CTD PMID:28329830 NCBI chr 4:115,446,830...115,454,035
Ensembl chr 4:115,448,708...115,453,659
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
ISO TNF protein inhibits the reaction [fluoranthene results in increased expression of TGFB1 mRNA] CTD PMID:18434080 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Tgif1 TGFB-induced factor homeobox 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TGIF1 mRNA CTD PMID:28329830 NCBI chr 9:119,181,079...119,190,698
Ensembl chr 9:119,181,083...119,190,698
JBrowse link
G Tgoln2 trans-golgi network protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TGOLN1 mRNA CTD PMID:28329830 NCBI chr 4:100,475,415...100,483,229
Ensembl chr 4:100,475,416...100,483,168
JBrowse link
G Thbd thrombomodulin multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of THBD mRNA
fluoranthene results in decreased expression of THBD mRNA
CTD PMID:28329830 NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325
JBrowse link
G Them4 thioesterase superfamily member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of THEM4 mRNA CTD PMID:28329830 NCBI chr 2:195,554,092...195,576,710
Ensembl chr 2:195,553,971...195,577,680
JBrowse link
G Them6 thioesterase superfamily member 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of THEM6 mRNA CTD PMID:28329830 NCBI chr 7:115,956,276...115,959,453
Ensembl chr 7:115,956,276...115,959,453
JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase increases expression
multiple interactions
EXP
ISO
fluoranthene results in increased expression of TIPARP mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of TIPARP mRNA
TNF protein inhibits the reaction [fluoranthene results in increased expression of TIPARP mRNA]
CTD PMID:25268939, PMID:28329830 NCBI chr 2:157,316,293...157,342,979
Ensembl chr 2:157,316,266...157,341,469
JBrowse link
G Tlcd1 TLC domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TLCD1 mRNA CTD PMID:28329830 NCBI chr10:65,439,104...65,441,140
Ensembl chr10:65,439,102...65,444,001
JBrowse link
G Tlcd3a TLC domain containing 3A multiple interactions
decreases expression
ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TLCD3A mRNA
fluoranthene results in decreased expression of TLCD3A mRNA
CTD PMID:28329830 NCBI chr10:64,360,374...64,367,679
Ensembl chr10:64,360,390...64,366,586
JBrowse link
G Tle5 TLE family member 5, transcriptional modulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TLE5 mRNA CTD PMID:28329830 NCBI chr 7:11,012,843...11,018,156
Ensembl chr 7:11,013,681...11,018,160
JBrowse link
G Tlnrd1 talin rod domain containing 1 decreases expression ISO fluoranthene results in decreased expression of TLNRD1 mRNA CTD PMID:28329830 NCBI chr 1:146,027,821...146,029,840
Ensembl chr 1:146,027,822...146,029,840
JBrowse link
G Tmem11 transmembrane protein 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TMEM11 mRNA CTD PMID:28329830 NCBI chr10:47,117,133...47,131,842
Ensembl chr10:47,117,135...47,131,842
JBrowse link
G Tmem140 transmembrane protein 140 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TMEM140 mRNA CTD PMID:28329830 NCBI chr 4:62,380,914...62,391,913
Ensembl chr 4:62,380,914...62,391,912
JBrowse link
G Tmem164 transmembrane protein 164 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM164 mRNA CTD PMID:28329830 NCBI chr  X:113,947,355...114,110,064
Ensembl chr  X:113,948,654...114,110,062
JBrowse link
G Tmem170a transmembrane protein 170A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM170 mRNA CTD PMID:28329830 NCBI chr19:44,090,418...44,101,365
Ensembl chr19:44,088,612...44,101,365
JBrowse link
G Tmem175 transmembrane protein 175 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM175 mRNA CTD PMID:28329830 NCBI chr14:2,083,745...2,100,006
Ensembl chr14:2,083,712...2,100,005
JBrowse link
G Tmem19 transmembrane protein 19 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM19 mRNA CTD PMID:28329830 NCBI chr 7:58,316,583...58,343,761
Ensembl chr 7:58,316,514...58,343,145
JBrowse link
G Tmem39a transmembrane protein 39a multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TMEM39A mRNA CTD PMID:28329830 NCBI chr11:64,723,181...64,752,514
Ensembl chr11:64,723,186...64,752,544
JBrowse link
G Tmem86a transmembrane protein 86A decreases expression
multiple interactions
ISO fluoranthene results in decreased expression of TMEM86A mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM86A mRNA
CTD PMID:28329830 NCBI chr 1:103,173,032...103,177,382
Ensembl chr 1:103,172,987...103,177,417
JBrowse link
G Tmem97 transmembrane protein 97 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM97 mRNA CTD PMID:28329830 NCBI chr10:65,811,455...65,820,538
Ensembl chr10:65,811,456...65,820,538
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases response to substance
ISO
EXP
TNF protein inhibits the reaction [fluoranthene results in increased expression of IL4 mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of TGFB1 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of CXCL8 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of IL6 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased secretion of CXCL8 protein]
TNF protein inhibits the reaction [fluoranthene results in increased expression of AHRR mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of TIPARP mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of CYP1B1 mRNA]
fluoranthene results in increased susceptibility to TNF protein
CTD PMID:18434080, PMID:25268939 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tnfaip3 TNF alpha induced protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFAIP3 mRNA CTD PMID:28329830 NCBI chr 1:14,401,103...14,416,369
Ensembl chr 1:14,402,913...14,412,807
JBrowse link
G Tnfaip6 TNF alpha induced protein 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFAIP6 mRNA CTD PMID:28329830 NCBI chr 3:37,545,238...37,564,704
Ensembl chr 3:37,545,238...37,564,699
JBrowse link
G Tnfrsf12a TNF receptor superfamily member 12A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFRSF12A mRNA CTD PMID:28329830 NCBI chr10:12,995,904...12,997,930
Ensembl chr10:12,995,904...12,997,930
JBrowse link
G Tnfrsf1b TNF receptor superfamily member 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFRSF1B mRNA CTD PMID:28329830 NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
JBrowse link
G Tnfrsf21 TNF receptor superfamily member 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TNFRSF21 mRNA CTD PMID:28329830 NCBI chr 9:20,546,159...20,621,051
Ensembl chr 9:20,546,159...20,621,051
JBrowse link
G Tns4 tensin 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNS4 mRNA CTD PMID:28329830 NCBI chr10:86,977,504...87,001,256
Ensembl chr10:86,977,505...87,001,256
JBrowse link
G Tob1 transducer of ErbB-2.1 decreases expression ISO fluoranthene results in decreased expression of TOB1 mRNA CTD PMID:28329830 NCBI chr10:81,913,689...81,915,727
Ensembl chr10:81,913,689...81,915,716
JBrowse link
G Top1 DNA topoisomerase I multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TOP1 mRNA CTD PMID:28329830 NCBI chr 3:156,635,688...156,717,686
Ensembl chr 3:156,642,464...156,717,686
JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
ISO fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]
fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 mRNA]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of TRP53 protein]; TRP53 results in increased susceptibility to [Benzo(a)pyrene co-treated with fluoranthene]
fluoranthene results in increased expression of TRP53 protein
CTD PMID:22120587 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Tp53bp2 tumor protein p53 binding protein, 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRP53BP2 mRNA CTD PMID:28329830 NCBI chr13:100,817,206...100,873,837
Ensembl chr13:100,817,359...100,873,890
JBrowse link
G Traf5 TNF receptor-associated factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRAF5 mRNA CTD PMID:28329830 NCBI chr13:110,758,556...110,801,871
Ensembl chr13:110,758,761...110,784,209
JBrowse link
G Trappc1 trafficking protein particle complex 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TRAPPC1 mRNA CTD PMID:28329830 NCBI chr10:55,924,996...55,926,582
Ensembl chr10:55,924,938...55,926,783
JBrowse link
G Trappc6a trafficking protein particle complex 6A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TRAPPC6A mRNA CTD PMID:28329830 NCBI chr 1:80,417,514...80,424,429
Ensembl chr 1:80,417,310...80,424,445
JBrowse link
G Trib1 tribbles pseudokinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIB1 mRNA CTD PMID:28329830 NCBI chr 7:99,954,492...99,961,026
Ensembl chr 7:99,954,492...99,961,026
JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIB3 mRNA CTD PMID:28329830 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
JBrowse link
G Trim33 tripartite motif-containing 33 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIM33 mRNA CTD PMID:28329830 NCBI chr 2:205,783,252...205,863,426
Ensembl chr 2:205,783,252...205,858,433